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An internal validation study was conducted using the PowerPlex® 16 HS system to ensure 
proper performance on the Applied Biosystems 3130 Genetic Analyzer in the University of 
Central Oklahoma laboratory.  Manual extraction with the DNA IQ™ system was performed.  
The Quantifiler™ Human Quantification kit was used to quantify the samples.  Promega 
Corporation’s PowerPlex® 16 HS system was used to amplify DNA samples on a GeneAmp® 
PCR System 9700 thermal cycler.  Separation occurred through capillary electrophoresis on an 
Applied Biosystems 3130 Genetic Analyzer.  Following parameters established through the 
validation, an environmental study was conducted to simulate casework samples.  The 
environmental study included ultraviolet treatment, tannic acid, humic acid, and hematin.  The 
results support the multiplexing system is capable of handling DNA samples. 
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As technology evolves, deoxyribonucleic acid (DNA) analysis procedures have become 
routine forensic tests that are performed in laboratories.  Forensic DNA testing involves the 
evaluation of biological material within evidence using DNA technologies and methodologies 
(DNA Advisory Board, 2000).  DNA analysis evaluates biological evidence, which consists of 
semen, blood, saliva, vaginal secretions, urine, and feces. 
Different environmental contaminants degrade biological material and inhibit the analysis 
process, which may prevent genetic profiles from being obtained.  The mission of manufacturers 
is to produce a commercialized amplification system that can handle forensic evidence.  An 
amplification system’s performance is vital when performing successful analysis of degraded 
and minute amounts of DNA.  Standards are set through the DNA Advisory Boards (DAB) 
guidelines to ensure quality results are achieved for inclusion into a national database.  The 
different multiplexing systems used to analyze casework are regulated by the National DNA 
Index System (NDIS) and must be tested and evaluated on the individual laboratory’s equipment.   
This study consisted of the examination of the PowerPlex® 16 HS system (Promega 
Corporation, Madison, WI, USA, #DC2100), particularly testing the strengths and limitations 
through the analysis of single source, mixed, and environmentally insulted blood samples.  An 
internal validation study was conducted to ensure proper functioning of the equipment present in 
the laboratory with the PowerPlex® 16 HS system.  Insight gained through the validation was 
then applied to all samples that were analyzed with the PowerPlex® 16 HS system.  At the 
conclusion of the manufacturers research, it was determined that the PowerPlex® 16 HS system 
had the ability to generate a profile from insulted samples (Promega Corporation, 2011).  An 
environmental study was conducted to evaluate the effect of known inhibitors to the 
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amplification process.  This more accurately depicts samples and results that would be obtained 
from casework DNA samples.  The study included samples that were insulted with ultraviolet 
treatment, tannic acid, humic acid, and hematin. 
 




Deoxyribonucleic Acid (DNA) 
The human genome.  
  DNA serves as the molecule of genetic inheritance.  The functional unit of DNA is the 
nucleotide monomer, which includes a 2’-deoxyribose, phosphoric acid, and a nitrogenous base, 
as seen in Figure 1.1 (Watson & Crick, 1953).  The sugar is a pentose compound, which contains 
five carbon atoms, and a 3’ hydroxyl group that is specific to DNA.  The phosphate group is 
bound to the 5’ carbon of the 2’-deoxyribose sugar molecule via a phosphoester bond.  The 
phosphate is negatively charged, which imparts an overall negative charge to the DNA molecule.  
Nucleotides are composed of the four bases, guanine, adenine, cytosine, and thymine, which 
form a glycosidic bond to the 1’ carbon of the 2’-deoxyribose (Watson & Crick, 1953).  The four 
bases are displayed in Figure 1.1.  Individual nucleotides polymerize to one another through the 
formation of phosphodiester bonds. 
The double helix structure of DNA is formed when complementary and anti-parallel 
chains of nucleotides anneal to one another, as shown in Figure 1.2.  The annealing of 
complementary bases is regulated and made stable through the formation of multiple hydrogen 
bonds (Watson & Crick, 1953).  Complementary bases cytosine and guanine pair to form three 
hydrogen bonds, whereas adenine and thymine result in the formation of two hydrogen bonds 
(Watson & Crick, 1953).   
The human genome is comprised of 23 pairs of chromosomes.  Located on each of these 
chromosomes are two distinct regions of DNA, coding regions and non-coding regions.  Coding 
regions consist of DNA that is transcribed and translated, and the regions are often referred to as 
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enzyme to break high quality genomic DNA in numerous locations called restriction sites.  Gel 
electrophoresis was used to separate the fragments of genomic DNA according to molecular 
weight.  The DNA fragments were placed on a membrane and hybridized to a probe to determine 
the length of the fragment.  The varying lengths were used as identifiers of individuals.  VNTRs 
are highly variable, which made them ideal for use in differentiation between individuals.  The 
time and labor intensive nature of VNTRs analysis were quickly replaced with more rapid forms 
of DNA analysis.  Over time, the methodology used by scientist shifted from VNTRs to short 
tandem repeats due to the new technologies developed, which has enabled improved analysis of 
samples (U.S. Department of Justice, 2000). 
Short tandem repeats (STRs). 
Several groups of tandemly repeated regions of DNA exist with varying patterns of base 
pairs.  Microsatellites, or short tandem repeats (STRs), usually contain 2 to 10 bp repeats.  STRs 
are useful genetic markers in a forensic setting that can be amplified by the polymerase chain 
reaction (PCR) (Ellegren, 2004).  Many STRs are located throughout the human genome; 
however, after extensive investigations only a few have been selected for use in forensic testing 
(Butler & Reeder, 2010).   
Thirteen STRs were chosen by the Federal Bureau of Investigation (FBI) to be utilized in a 
national database that serves as a library for genetic profiles.  CSF1PO, FGA, TH01, TPOX, 
vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, and D21S11 are 
referred to as the thirteen Combined DNA Index System (CODIS) Core STR Loci in the United 
States (Budowle, Moretti, Niezgoda, & Brown, 1998).  STR loci are unlinked, found on different 
chromosomes, or located on distant regions of the same chromosome.  An advantageous 
characteristic that makes STRs useful within forensic analysis is their  high discrimination factor, 
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which provides a differentiation ability with individuals in the population through 
distinguishable alleles (Butler & Reeder, 2010).  STRs are compatible with multiplexing, which 
allows the amplification of all thirteen DNA targets in one PCR tube.  Low stutter and mutation 
rates exist with STR loci.  Most STRs utilized in forensic testing are tetrameric (Bacher et al., 
1998).  Tetrameric STRs have been proven to efficiently identify individuals with low levels of 
mutations present (Caskey, Chakraborty, Edwards, Hammond, & Jin, 1992).  STRs have high 
heterozygosity levels that present genetic variability throughout the human population.  STRs 
offer ideal markers for forensic DNA testing. 
DNA Analysis 
The methodology for the forensic analysis of DNA samples begins with DNA extraction. 
The goal of extraction is to separate genomic DNA from a biological sample located on a 
substrate.  The sample must then be quantified.  During the quantification step, DNA is measured 
to estimate the amount of usable DNA that exists within a sample.  Information that is obtained 
from DNA quantitation will be utilized during the amplification phase of analysis.  The PCR 
process exponentially copies DNA to generate quality DNA amplicons.  Genetic analysis of the 
amplicons is performed through capillary electrophoresis (CE), a form of chromatography.  The 
resulting data are obtained and analyzed as a genetic profile. 
DNA Extraction and the DNA IQ™ System 
The DNA IQ™ system is an extraction method available from Promega Corporation that 
utilizes paramagnetic beads to extract and purify DNA from cellular components, PCR 
inhibitors, and other problematic material commonly associated with forensic casework samples 
(Promega Corporation, 2009).  The paramagnetic resins that are used to attract and hold DNA  
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are positively charged.  The negative charge of DNA allows a strong interaction to occur, which 
binds the phosphate backbone of DNA to the resin throughout the extraction process.  
Extraction process. 
The DNA IQ™ system extraction process incorporates numerous chemistries designed to 
break the cell membrane, purify the DNA, and stabilize the DNA throughout the protocol.  The 
DNA IQ™ system lysis buffer functions to liberate the DNA from the cells located on the item 
of evidence.  Proteinase K, sodium dodecyl sulfate (SDS), and dithiothreitol (DTT) within the 
lysis buffer help to free cells from a sample by breaking down the proteins, lysing the cellular 
membranes, and disrupting the disulfide bonds that bond the cell membrane together 
respectively.  Paramagnetic resin is used to bind the DNA located within the sample.  Wash 
buffer is used to clean the sample of any components that may interfere with the PCR process.  
Elution buffer is used to neutralize the charge of DNA, which releases the bond of the resin and 
DNA. 
The DNA IQ™ system is advantageous for use in forensic casework due to a lack of 
hazardous chemicals involved throughout the process and reduced occurrences of contamination 
(Promega Corporation, 2009).  The main concern with the DNA IQ™ system lies with the 
amount of DNA that is extracted from the sample.  The limit exists with the amount of DNA the 
paramagnetic resin can bind.  The binding affinity of the resin for FTA blood-card punches is 50 
to 100 ng of DNA, liquid whole blood is 50 to 200 ng of DNA, and buccal swabs is 100 to 500 
ng of DNA (Promega Corporation, 2009).  
DNA Quantification and the Quantifiler™ Human Quantification Kit 
DNA quantification serves to identify the concentration of amplifiable human DNA in a 
given sample (Nicklas & Buel, 2003).  This process is required by the DAB in casework extracts 
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using a standard method, which is specific for human nuclear DNA (DNA Advisory Board, 
2000).  The Quantifiler™ Human DNA Quantification kit is an upper primate specific nuclear 
DNA quantitation assay manufactured by Applied Biosystems, a Life Technologies company, 
using real-time PCR methods. 
The Quantifiler™ human quantification assay utilizes two 5’ nuclease assays, a human 
specific assay and an internal PCR control assay (Applied Biosystems, 2010).  The human 
telomerase reverse transcriptase (hTERT) gene on chromosome 5p15.33 amplifies a non-
translated region of DNA (Applied Biosystems, 2010).  The internal PCR control components 
include synthetic template, two primers, and a TaqMan probe used to detect the amplified DNA 
(Applied Biosystems, 2010).   
TaqMan probe. 
The TaqMan probe utilizes a reporter dye linked to the 5’ end of the probe, a minor groove 
binder linked to the 3’ end of the probe, and a non-fluorescent quencher at the 3’ end of the 
probe (Applied Biosystems, 2010).  During real-time PCR, the TaqMan probe anneals to the 
complementary sequence between the primers, and the reporter dye and quencher dye are 
suppressed on the probe (Applied Biosystems, 2010).  As the DNA polymerase travels from the 
5’ end toward the 3’ end, the reporter dye is cleaved and separated from the quencher resulting in 
a fluorescence signal released (Applied Biosystems, 2010).  The TaqMan probe method is 
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50 to 60 °C (Saiki et al., 1988).  PCR is concluded by elongation conducted at 72 °C, the 
optimum temperature for Taq DNA polymerase (Saiki et al., 1988).  Elongation synthesizes the 
DNA strands (Saiki et al., 1988).  Taq polymerase is a heat stable DNA polymerase, which is 
beneficial for PCR.  Figure 1.4 depicts the phases of PCR. 
Several components and reagents are used to perform PCR, which include DNA 
polymerase, dNTPs, primers, DNA template, buffer, divalent cations, and water (Butler, 2005).  
DNA polymerase is the enzyme that synthesizes the nucleotides of the new DNA strand to the 3’ 
end.  Nucleotides, also called dNTP’s, are the building blocks of DNA.  Primers or 
oligonucleotides are short DNA sequences that flank the target region that will be copied, and 
they are necessary because DNA polymerase cannot synthesize a new strand without having 
starting material.  Buffer maintains and controls the pH of the reaction.  Divalent cations are used 
to help the DNA polymerase facilitate the reaction.  Water is utilized to bring the overall mix to 
its final volume.   
Commercialized manufactured systems combine most components that are necessary for 
the PCR process into a master mix.  The master mix includes everything except the DNA 
template, and it is used to avoid human mistakes that could occur in pipetting small amounts of 
materials (Butler, 2005).   
A major component for amplifying a DNA strand is the DNA polymerase, which 
synthesizes the new strand.  PCR utilizes Taq DNA polymerase, which originates from the 
bacterium Thermus aquaticus.  Thermus aquaticus is a prokaryote that can survive at extremely 
high temperatures, and allows for a quick and direct method to amplify DNA (Innis, Myambo, 
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Capillary Electrophoresis (CE) is a form of chromatography that is used to separate various 
materials.  CE separates DNA through movement of a mobile phase in a stationary phase 
evaluated by molecular weight and shape.   
CE identifies fluorescently labeled DNA products of the PCR process.  Various sized 
products move through the capillary based on the fragment size and charge.  In genetic analysis, 
the stationary phase within the capillary is composed of Performance Optimized Polymer 4 
(POP-4) (Lazaruk et al., 1998).  The mobile phase consists of DNA fragments moving through 
the POP-4 within capillaries.  POP-4 has the capability to separate microsatellites, specifically 
separate DNA fragments that differ in size from 1 to 250 nucleotides (Lazaruk et al., 1998).  The 
polymer used in forensics coats the inside of the capillary to control the electro-osmotic flow of 
DNA (Lazaruk et al., 1998).  Movement is based on the electrical current that runs from the 
anode to the cathode, which drives the DNA to migrate through the capillary (Department of 
Justice, 2004).  The shortest fragments of DNA move through the capillary with more ease than 
the larger fragments thus they move more quickly through the polymer.  A laser is used to 
identify the color of light that is given off through the 5’ fluorescent tag attached to the single 
stranded DNA (Department of Justice, 2004).  The burst of light is captured by the charge-
coupled device (CCD) camera.  The bursts are reported as peaks on an electropherogram for an 
analyst to interpret (Department of Justice, 2004). 
Forensic analysis. 
The steps for forensic labeling are: data collection, peak recognition, color separation, peak 
sizing, allelic ladder comparison, and allele assignment (Butler, Buel, Crivellente, & McCord, 
2004).  The peak is sized by comparison to an internal size standard that is run concurrently with 
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all samples.  An allelic ladder is run with every batch of samples, and it represents common 
known allele sizes at a specific locus (Butler et al., 2004). 
Numerous characteristics have been determined to be necessary for a separation and 
detection technique utilized in forensic casework which are: “reliable sizing over a 75 to 500 bp 
size range, high run-to-run precision between processed samples to permit comparison of allelic 
ladders to sequentially processed STR samples, effective color separations of different dye sets 
used to avoid bleed through between four or five different colors, and finally, resolution of at 
least one base-pair to approximately 350 bp to permit reliable detection of microvariant alleles” 
(Butler et al., 2004). 
Capillary Electrophoresis instruments, like the Applied Biosystems 310 Genetic Analyzer, 
3100 Genetic Analyzer, and 3130 Genetic Analyzer are common in forensic laboratories that 
analyze STRs (Department of Justice, 2004).   
Numerous advantages exist with little preparation time needed when performing CE.  CE 
is fully automated, and easy to use with little time necessary for set up and preparation (Butler et 
al., 2004).  CE has better reproducibility due to the polymer type used and the little affect 
bubbles have on the process (Butler et al., 2004).  Greater resolution is due to effective heat 
dissipation (Butler et al., 2004).  Due to the numerous wash and rinse steps, cross-contamination 
between samples is significantly reduced (Butler et al., 2004).  Finally, small quantities are 
required to perform CE. 
Promega’s PowerPlex® 16 HS System 
The PowerPlex® 16 HS system is a second generation multiplexing system that is new to 
forensic DNA testing.  The PowerPlex® 16 HS system amplifies sixteen locations in the human 
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genome, 15 STR loci and Amelogenin, in a three color detection system (Promega Corporation, 
2011).   
The PowerPlex® 16 HS loci consist of: Penta E, D18S51, D21S11, TH01, D3S1358, FGA, 
TPOX, D8S1179, vWA, Amelogenin, Penta D, CSF1PO, D16S539, D7S820, D13S317, and 
D5S818 (Promega Corporation, 2011).  Three different fluorescently labeled dyes are used to 
label the primers.  The fluorescein (FL) dye labels D3S1317, TH01, D21S11, D18S51, and Penta 
E (Promega Corporation, 2011).  Carboxy-tetramethylrhodamine (TMR) is used to label FGA, 
TPOX, D8S1179, vWA, and Amelogenin; and 6-carboxy-4’,5’-dichloro-2’7’-dimethoxy-
fluorescein (JOE) is used to label Penta D, CSF1PO, D16S539, D7S820, D13S317, and D5S818 
(Promega Corporation, 2011).  The internal lane standard 600 is labeled with carboxy-X-
rhodamine (Promega Corporation, 2011).  Figure 1.5 depicts the dye colors and 16 loci 
examined.   
Second generation system. 
The PowerPlex® 16 HS system has a newly designed master mix, which includes a hot 
start Taq polymerase.  A monoclonal antibody blocks the polymerase activity of Thermus 
aquaticus (Kellogg et al., 1994).  The antibody prevents Taq polymerase from beginning 
amplification when it is added to the PCR reaction at room temperature (Kellogg et al., 1994).  
During the initial denaturation step, the antibody is denatured to regain full enzyme activity 
(Genesis Biotech Inc.). 
“The ILS 600 contains 22 fragments of 60, 80, 100, 120, 140, 160, 180, 200, 225, 250, 
275, 300, 325, 350, 375, 400, 425, 450, 475, 500, 550, and 600 bases in length” (Promega 
Corporation, 2011).  The allelic ladder contains common alleles observed within the population 
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Data analysis of DNA encompasses numerous different artifacts and unwarranted peaks 
within a genetic profile.  When DNA is degraded, the sequence of STRs can be interrupted 
resulting in unsuccessful amplification. 
Spurious peaks. 
A detection threshold is established to separate baseline noise from a true allele.  The 
threshold value is set by the individual laboratory according to a validation study.  Artifacts can 
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occur within a profile that include dye blobs, spikes, and noise.  Artifacts are generally 
instrument related malfunctions or small chemical problems (Department of Justice, 2004). 
A dye blob is the breakdown of a fluorescent dye tag on a primer (Applied Biosystems, 
1988).  Dye blobs are typically wider peaks with a rounded apex.  Spikes are short intense peaks 
that are thought to be caused by air bubbles within the equipment or fluctuations in the electrical 
current within the Applied Biosystems 3130 Genetic Analyzer (Department of Justice, 2004).  
Spikes are not reproducible.  Noise is non-reproducible peaks that are caused by many factors 
such as air bubbles, crystals, contamination, or current fluctuations in the equipment 
(Department of Justice, 2004).  Pull-up is an artifact that occurs when dyes bleed into additional 
color channel (Department of Justice, 2004).  Pull-up results from too much DNA being injected 
into the analyzer, or the spectral calibration failing to discriminate between dye colors 
(Department of Justice, 2004).   
Stutter is an artifact represented by a peak which is one repeat unit smaller or larger than 
the principal allele observed (Walsh, Fildes, & Reynolds, 1996).  Stutter is a frequent occurrence 
with the amplification process, and it is a reproducible and predicted artifact.  Slipped-strand 
mispairing is thought to explain how stutter is formed (Walsh et al., 1996).  The DNA 
polymerase becomes detached during synthesis, as it re-anneals a loop occurs that creates a PCR 
product one repeat smaller (Walsh et al., 1996).  Stutter calculations are performed by dividing 
the peak height value of the stutter peak by the peak height value of the true allele. 
Non-template addition is an additional peak that is one base pair longer than the principal 
allele, usually ‘+A’ or ‘-A’ (Clark, 1988).  An extra nucleotide is added to the 3’ end of the 
amplification product.  The result occurs because DNA polymerase is not able to finish the 
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elongation step of PCR for all products.  Multiplexing systems are designed to limit the addition 
of adenine. 
Microvariants and off-ladder (OL) alleles occur when an allele is detected that is not 
present in the allelic ladder.  An allelic ladder contains the most prevalent alleles seen in a 
population.  Unique or rare alleles may not be present within the allelic ladder.  A microvariant 
occurs when an allele contains incomplete repeat units.  Microvariants may be called an off-
ladder allele because it does not size to a known reference bin within the allelic ladder. 
DNA imbalance. 
Stochastic effects are the unequal sampling of two alleles in an individual who is 
heterozygous at a particular locus.  Stochastic effects often occur in degraded DNA sample, 
when low quantities of DNA are amplified.  The Scientific Working Group on DNA Analysis 
Methods (SWGDAM) (2010) recommends a 60% value to be used when determining if a 
heterozygote imbalance occurs.  Allelic dropout occurs when an allele is not present within the 
genetic profile that otherwise should.   
Mutations are changes in the DNA sequence.  They can occur in primer binding areas or 
within the STR amplified region (Ellegren, 2004).  Null alleles are alleles that are not amplified 
due to primer binding region mutations.  Null alleles are rare due to the elevated level of success 
that DNA multiplexing systems are manufactured with today (Budowle, 2000). 
Validation Process 
Validation refers to a forensic laboratory demonstrating procedures that are robust, 
reliable, and reproducible using specific chemistries on specific instrumentation (Butler & 
Reeder, 2010).  A validation is robust if successful results are obtained consistently with few 
errors forcing a procedure to be repeated (Butler & Reeder, 2010).  Reliability ensures correct 
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results are gathered from tests, and reproducibility ensures the same results will be obtained each 
time a sample is tested (Butler & Reeder, 2010).  Two forms of a validation are established and 
required in forensic science, a developmental and internal validation. 
Developmental validation. 
Developmental validations ensure accuracy, precision, and reproducible results.  The 
developmental validation “is the acquisition of test data and determination of conditions and 
limitations of a new or novel DNA methodology for use on forensic samples” (DNA Advisory 
Board, 2000).  It is used primarily to test new STR multiplexing systems, STR loci, primer sets, 
and new innovations (Butler & Reeder, 2010).  The requirements of a developmental validation 
are species specificity, sensitivity, stability, mixture studies conducted, and population 
distribution data available for use (DNA Advisory Board, 2000).   
PowerPlex® 16 HS system developmental validation. 
A developmental validation was performed using PowerPlex® 16 HS, which found it to be 
accurate and consistent when used on forensic samples (Ensenberger et al., 2010).  Within the 
PowerPlex® 16 HS system, the primers used were human specific, it was able to resist inhibitors 
amplification, reproducible results between numerous laboratories were obtained, it held up 
against forensic case samples and mixtures, and the protocol for PCR designed by the 
manufacturer was sufficient in their instruction (Ensenberger et al., 2010).   
The results of the developmental validation are an important key to laboratories 
determining whether to validate the system for internal use.  The developmental validation 
included a species specificity test.  Twenty-eight non-human samples were tested, and no peaks 
were detected in the STR loci.  A sensitivity study was conducted, to determine the lowest 
amount of input DNA the system could withstand when analyzing samples.  The study 
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concluded, when using a 32 cycle amplification protocol, 85% of alleles were called with 31.25 
picograms (pg) of DNA (Ensenberger et al., 2010).  In a 30 cycle amplification protocol more 
than 50% of alleles were called with 62.5 pg of DNA (Ensenberger et al., 2010).  A 
reproducibility and concordance study was carried out to ensure alleles were called correctly and 
consistently when samples were re-analyzed.  The results determined complete concordance was 
displayed (Ensenberger et al., 2010).  The peak height ratios were evaluated at heterozygous loci 
for 313 samples.  This examination aided the process to set a stochastic threshold.  The average 
peak height ratio was 0.86 with a standard deviation of 0.10 (Ensenberger et al., 2010).  A 
mixture study was conducted on the following ratios: 19:1, 9:1, 5:1, 2:1, 1:1, 1:2, 1: 5, 1:9, and 
1:19 (Ensenberger et al., 2010).  All minor alleles ranging between 5:1 and 1:5 were identified 
(Ensenberger, et al., 2010).  Between 9:1 and 1:9, over 90% of minor alleles were detected and 
present; however,  the ratios 19:1 and 1:19 only detected minor alleles for around 70% of the 
data (Ensenberger, et al., 2010).  The findings of the study concluded that the PowerPlex® 16 
HS system is adequately prepared to analyze samples that were comprised of low quality and 
quantity DNA (Ensenberger, et al., 2010). 
A developmental validation focuses on the accuracy of the multiplexing system, whereas 
an internal validation is performed by the individual laboratories to ensure the multiplexing 
system works properly on the instrumentation that will run casework samples.   
Internal validation. 
An internal validation is an “accumulation of test data within the laboratory to demonstrate 
that established methods and procedures perform as expected in the laboratory” (DNA Advisory 
Board, 2000).  The requirements include testing on known and non-probative evidence, 
documented reproducibility, and precision for human samples (DNA Advisory Board, 2000). 
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Numerous different components comprise an internal validation study.  A detection 
threshold study is conducted to determine a threshold above which allele calls are confidently 
recognized as true alleles.  The detection threshold separates baseline noise recorded on the 
instrument from true allele peaks.  A dynamic range and sensitivity study establishes a range of 
DNA concentrations in which a complete and useable genetic profile is obtained with no allele 
dropout or off-scale products observed.  The stochastic threshold is studied to establish a level 
that confidently recognizes two alleles as sister alleles if their peak heights exceed the threshold 
value.  Stochastic thresholds play a large role in mixture deconvolution.  Precision is studied to 
determine the accuracy and reproducibility of the CE instrument used in the laboratory.  A stutter 
study is conducted to examine all stutter peaks that occurred when analyzing a sample.  Stutter is 
a known and reproducible artifact; therefore, it can be analyzed and a percentage can be set for 
every locus examined.  A mixture study establishes interpretation guidelines when dealing with 
two source DNA profiles.  A contamination study is run to ensure carry over is not present 
between capillaries.  Finally, a mock case is conducted to ensure proper processing of casework 
simulated samples by the analyst and instrumentation. 
An internal validation of the PowerPlex® 16 HS system was performed by the CeSAAN 
Laboratory in Venezuela, which concluded this kit was able to produce results when samples 
contained degraded and small amounts of DNA (Caraballo, Loyo, Sanchez, & Takiff, 2009).  Its 
use has been credited with increasing the types of samples that have been successfully analyzed 
to identify human genetic markers (Caraballo et al., 2009). 
Environmental Inhibitors 
Crimes occur in nature; therefore, numerous factors within the environment affect the 
longevity and life of the evidence deposited in a scene.  Due to the standards that forensic 
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methodologies must withstand to be admitted into a court of law, it must be demonstrated the 
multiplexing system chemistries have the ability to analyze real-world samples.   
Previous studies were performed by the FBI that evaluated environmental insults, different 
substrates, and contaminants when RFLP analysis was the standard within the field (Adams et 
al., 1991).  Common links between RFLP analysis and PCR analysis include the utilization of 
probes and primers that label target DNA.  Due to the nature of crimes, environmental inhibitors 
need to continually be evaluated as new technology evolves to analyze DNA samples.  The 
inhibitors that were focused on in this study are ultra violet treatment, tannic acid, humic acid, 
and hematin. 
Ultra Violet (UV) treatment. 
UV treatment simulates the effect of sunlight on a DNA sample.  UV irradiation effects the 
structure and break down of DNA (Klouwen, Appelman, & Barendsen, 1962).  Figure 1.7 
depicts the break in DNA bonds.  “UV treatment induces cyclobutane dimmers (CPD), 
pyrimidine-pyrimidone (6-4) photoproducts and DNA-protein cross-links” (Sgura, Meschini, 
Antoccia, Palitti, Obe, & Tanzarella, 1996).  “CPDs are formed at TT, TC-CT, and CC 
sequences, with a frequency of 50, 40, and 10% respectively” (Ellision & Childs, 1981).  
“Structural studies indicate that the presence of CPDs leads to a distortion of the DNA double 
helix” (Pearlman, Holbrook, Pirkle, & Kim, 1985).  CPDs and 6-4PPs induce a bend in DNA 
(Thoma, 1999).  The “structural distortion” seen through these studies is believed to be the 
reason degradation exists in the DNA double helix (Pang & Cheung, 2007).  The DNA 
polymerase is blocked from synthesizing the strand during PCR by the location of dimmers 
(Pang & Cheung, 2007).  This degradation is efficient in breaking down the DNA molecule 
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A study of soil inhibition was conducted using RFLP technology.  Stains were prepared 
with 50 µL of blood and 0.1 g of air dried soil (Adams et al., 1991).  The stains were air dried 
and analyzed.  The results revealed “components of the soil physically inhibited DNA extraction 
rather than that DNA was degraded by enzymes present in the soil” (Adams et al., 1991).    
Kontanis and Reed (2006) tested the ability of real-time PCR to withstand DNA inhibited 
with tannic acid.  “Tannic acid powder was serially diluted (0.2, 0.4, 0.6, 0.8, 1.0, 1.2, and 1.4 
ng/µl) in water to act as the inhibitory agent” (Kontanis & Reed, 2006).  Inhibition was directly 
related to the amount of tannins in the reaction (Kontanis & Reed, 2006).  Complete inhibition of 
real-time PCR occurred with 1.4 ng per 25 µl reaction (Kontanis & Reed, 2006). 
Humic acid. 
Humic acid is a PCR inhibitor that is frequently associated with samples found in soil.  
Humic acid is a known PCR inhibitor, affecting the annealing of primers to template DNA, and 
preventing Taq DNA Polymerase from synthesizing DNA strands.   
Humic acid “can inhibit the polymerase activities or binding of primers and reduce the 
sensitivity of detection” (Tsai & Olson, 1992).  Humic substances are found in high organic 
contents within soil (Young, Burghoff, Keim, Minak-Bernero, Lute, & Hinton, 1993).  “Humic 
acids with phenolic groups that denature biological molecules by bonding to N-substituted 
amides or proteins” inhibit PCR (Young et al., 1993).  Dilution can alleviate the effect of humic 
acid on a PCR reaction; however, the detection limit will decrease (Tsai & Olson, 1992). 
Tsai and Olson (1992) stated that, “as little as 1 µl of undiluted humic-acid-like extract 
from high-CEC sediments is sufficient to completely inhibit PCR regardless of the amount of 
DNA present in the 100 µl reaction mixture”.   
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In a study conducted by Applied Biosystems during the validation of AmpFℓSTR® 
Identifiler® Plus PCR Amplification Kit, humic acid was examined.  The concentrations used 
were 0, 50, 100, and 150 ng/µl (Applied Biosystems, 2010).  All of the concentrations yielded 
full genetic profiles following analysis. 
Hematin. 
Hematin, a derivative of hemoglobin, is a PCR inhibitor that is found in blood.   Many 
inhibitors within blood affect PCR such as heme, leukocyte DNA, EDTA, and heparin (Al-Soud 
& Radstrom, 2001).  Hemoglobin contains iron, which inhibits PCR through the ability to release 
iron ions (Al-Soud & Radstrom, 2001).  Hemin regulates DNA polymerase activity by 
resembling MgCl₂, and it is competitive with the DNA template (Al-Soud & Radstrom, 2001).  
Hematin inhibits Taq DNA polymerase activity in PCR by weakening the binding of any ligand 
to iron heme (Akane, Kazuo, Nakamura, Takahashi, & Kimura, 1994).  In a study conducted by 
Akane et al. (1994), 0.25 µM of alkaline or acid hematin inhibited PCR amplification. 
In a previous study conducted during the validation study of Applied Biosystems 
AmpFℓSTR® Identifiler® Plus PCR Amplification Kit, a hematin study was performed (Applied 
Biosystems, 2010).  The concentrations used were 0, 100, 200, and 300 µM of hematin (Applied 
Biosystems, 2010).  All concentrations failed to inhibit the samples. 
Objectives 
The objective of this study was to conduct an internal validation of the PowerPlex® 16 HS 
system within the University of Central Oklahoma forensic science laboratory.  This would allow 
the implementation of this system when examining forensic samples.  A second objective 
encompassed testing the overall strengths and limitations of the PowerPlex® 16 HS system.  
Through testing different quantities and qualities of DNA that were subjected to environmental 
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factors the limitations of the kit were observed.  The environmental factors that were analyzed 
were UV treatment, tannic acid, humic acid, and hematin.  Overall, a thorough review of the 
PowerPlex® 16 HS system was performed to analyze the data obtained when completing the 





 Materials and Methods  
DNA testing occurred in Edmond, Oklahoma at the University of Central Oklahoma’s 
biology laboratory in Howell Hall.  Single source biological material, specifically blood, was 
obtained from Innovative Research (Novi, MI, USA).  One single source sample was used to 
conduct all phases of this research except the mixture study.  Two single source blood samples 
were used to fulfill the mixture study. 
Procedures 
All DNA samples used during this research were manually extracted with the Promega 
DNA IQ™ system (Promega Corporation, Madison, WI, USA, #DC6700).  The Quantifiler™ 
Human DNA Quantification kit (Applied Biosystems, Carlsbad, CA, USA, #4343895) was used 
on an Applied Biosystems 7500 Real-Time PCR System (Serial No.275001373) for human 
identification to quantify all DNA samples.  Amplification of all DNA samples was conducted 
using the PowerPlex® 16 HS system chemistry (Promega Corporation, #DC2100) on an Applied 
Biosystems GeneAmp® PCR System 9700 thermal cycler (Serial No.805S8201803).  An 
Applied Biosystems 3130 Genetic Analyzer (Serial No.21364-025) was employed to separate all 
DNA samples for this research.  Data obtained from the Genetic Analyzer was interpreted using 
the Applied Biosystems GeneMapper® Software version 3.2.  All methods were guided by the 
DNA Advisory Boards (DAB) guidelines Standard 8.1 in accordance with performing a 
validation study (DNA Advisory Board, 2000).  An attempt was made to follow all guidelines set 
forth for DNA analysts working in a laboratory; however, due to the public location that the tests 
were conducted, control of all variables was not possible. 
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DNA IQ™ System Protocol 
A cutting or portion of a sample was taken from the evidence and placed in a Seal Rite 2.0 
milliliter (ml) Natural Microcentrifuge tube (USA Scientific, #1620-2700). As per DAB 
guidelines, a reagent blank control sample was created at the time of extraction.  The reagent 
blank was treated just like a sample; however, it did not contain an actual DNA sample.  It was 
used to measure potential contamination that could occur throughout the procedure, through 
contaminated reagents, environmental contamination, or analyst contamination. 
Samples were exposed to a specified amount of the provided lysis buffer.  The amount of 
lysis buffer was dependent on the substrate the sample was located on.  All samples were 
incubated on a Dri-bath (Thermolyne Type 16500, #229920807548) at 70 °C for 30 minutes to 
aid cellular membrane denaturation.  The tubes were removed from the heat source, the substrate 
the samples were collected on transferred to individual spin baskets (Promega Corporation, 
#V1221) and seated in the same 2.0 ml microcentrifuge tube.  The spin basket and tube apparatus 
for each sample was centrifuged at room temperature for 2 minutes.  The spin baskets were 
removed and discarded.  Seven microliters (µl) of DNA IQ™ Resin was added to each tube.  For 
5 minutes, the resin, lysis buffer, and sample mixtures were vortexed and incubated at room 
temperature.  The sample tubes were placed on a manufacture provided magnetic stand where 
the magnetic resin separated from the lysis buffer almost instantaneously.  The lysis buffer from 
each sample was removed and discarded.  The magnetic resin and DNA pellets of each sample 
were not disturbed.  An additional 100 µl of lysis buffer was added to the tubes DNA and resin 
pellet.  The tubes were removed from the magnetic stand, vortexed for 2 seconds, returned to the 
magnetic stand, and the lysis buffers were discarded following separation.  One-hundred 
microliters of 1X Wash Buffer, provided in the kit, was added to the samples.  The tubes were 
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removed from the magnetic stand, vortexed for 2 seconds, returned to the magnetic stand, and 
the wash buffer from each sample was discarded following separation.  This process was 
repeated for a total of three wash steps for each tube.  Following the last wash buffer discard 
step, the tubes were left open on the magnetic stands to allow the resin to air dry for 5 minutes. 
Caution was paid to all samples at this point so that cross-contamination did not occur.   Elution 
buffer was added to the tubes ranging between 25 µl and 100 µl dependent on the amount of 
biological material used in each sample.  The tubes were vortexed for 2 seconds, and incubated 
at 65 °C for 5 minutes.  Subsequent to removal from the heat source, the tubes were vortexed and 
returned to the magnetic stands.  The DNA is no longer fixed to the resin because it is now 
located within the elution buffer.  The elution buffer and DNA was transferred to another tube 
for each sample extracted (Promega Corporation, 2009). 
Quantifiler™ Human Quantification Kit Protocol 
The following procedure was performed for all quantification reactions.  Eight standards 
were concurrently run with every real-time PCR procedure.  A serial dilution was created to 
achieve the following DNA standard concentrations: 50.000 ng/µl (Standard 1), 16.700 ng/µl, 
5.560 ng/µl, 1.850 ng/µl, 0.620 ng/µl, 0.210 ng/µl, 0.068 ng/µl, and 0.023 ng/µl (Standard 8) 
(Applied Biosystems, 2010).  Standard one is composed of 10 µl of 200 ng/µl stock and 30 µl of 
sterile water. 
Two components were used to form a master mix, which was added to every well that 
contained a standard, DNA sample, or reagent blank.  A volume of 10.5 µl Quantifiler Human 
Primer Mix and 12.5 µl Quantifiler PCR Reaction Mix was added to each reaction.  The primer 
mix was thawed completely and vortexed for 3 to 5 seconds.  The Quantifiler PCR reaction mix 
was swirled gently.  The appropriate volumes of both components were pipetted into a 2.0 ml 
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microcentrifuge tube.  The mixture was vortexed, and centrifuged.  Twenty-three microliters of 
the mix was dispensed into each reaction well.  Two microliters of DNA sample or standard was 
added to each reaction well.  The MicroAmp® Optical 96-well Reaction Plate (Applied 
Biosystems, #N801-0560) was covered with an MicroAmp® Optical Adhesive Film (Applied 
Biosystems, #4311971) and placed on the Applied Biosystems 7500 Real-Time PCR System 
(Applied Biosystems, 2010). 
PowerPlex® 16 HS System Amplification Protocol 
Amplification set-up. 
PowerPlex® HS 5X Master Mix and PowerPlex® 16 HS 10X Primer Pair Mix were added 
to each PCR reaction.  The number of reactions was determined, which included all samples to 
be amplified, a positive control, a negative control, and a reagent blank associated with the 
extracted and quantified samples.  The reaction volume of each amplification was determined by 
the following ratios: 5.0 µL PowerPlex HS 5X Master Mix, 2.5 µL PowerPlex HS 10X Primer 
Pair Mix, up to 17.5 µL Template DNA (range of 0.5-1.0 ng), and water to a final volume of 
25.0 µL.  The PCR amplification mix of PowerPlex® HS 5X Master Mix and PowerPlex® 16 
10X Primer Pair Mix were distributed into each tube followed by template DNA into each tube.  
A PCR tube for a positive control and negative control were made.  The positive control 
contained known 9947A DNA.  The negative control contained 5.0 µl Master Mix, 2.5 µl Primer 
Mix, and 17.5 µl of sterile amp grade water.  The PCR tubes were placed on the GeneAmp® 
PCR System 9700 thermal cycler (Promega Corporation, 2011). 
Thermal cycling parameters. 
The GeneAmp® PCR System 9700 thermal cycler was set to emulate the operation mode 
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PowerPlex® 16 HS System Genetic Analyzer Protocol 
The Applied Biosystems 3130 Genetic Analyzer was used to obtain genetic profiles 
through capillary electrophoresis.  A loading cocktail was prepared by combining Internal Lane 
Standard (ILS) 600 and formamide at the ratio: [(0.5µl ILS 600) ˟ (# injections)] + [(9.5µl 
formamide) ˟ (# injections)] (Promega Corporation, 2011).  Ten microliters of the formamide 
and ILS mix was deposited into each well.  One microliter of amplified sample was added to 
each designated well.  The plate was denatured at 95 °C for 3 minutes and then immediately snap 
cooled for 3 minutes on ice.  The plate was loaded onto the Applied Biosystems 3130 Genetic 
Analyzer (Promega Corporation, 2011). 
STR Data Analysis 
To interpret the data obtained, GeneMapper® ID software version 3.2 was used for 
fragment sizing and allele calling.  Peaks represent DNA fragments following electrophoresis, 
which are sized based on the internal lane standard run simultaneously.  STR fragments are sized 
based on the Local Southern Method, using the ILS 600 peaks surrounding the unknown 
fragment to determine an allele call.   
Electropherograms for all analyzed samples were obtained, which contained the genetic 
profile represented by peaks within the 15 STR loci’s examined bins and Amelogenin.  This 
software was used to interpret each sample for artifacts and amplified DNA products.   
Validation Protocol 
To determine the dynamic range, sensitivity, stochastic threshold, precision of capillary 
electrophoresis, reproducibility, and stutter ratios, the following quantities of DNA were 
amplified and analyzed with the protocols previously described: 5.00 ng, 2.50 ng, 1.25 ng, 0.63 
ng, 0.31 ng, 0.16 ng, 0.08 ng, 0.04 ng, 0.02 ng, and 0.01 ng.  DNA was extracted and quantified 
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prior to the amplification and separation process.  Five replicated samples of each concentration 
were analyzed and evaluated. 
All data was amplified using Promega’s PowerPlex® 16 HS system, with 32 cycles on a 
GeneAmp® PCR System 9700 for 5 seconds at 3 kV.  Capillary electrophoresis was performed 
on an Applied Biosystems 3130 Genetic Analyzer, 36 cm 4-capillary array (Applied Biosystems, 
#4333464) with POP-4 (Applied Biosystems, #4352755). 
Detection threshold. 
To establish the detection threshold, or analytical threshold, for the Applied Biosystems 
3130 Genetic Analyzer, six negative controls were analyzed under various parameters.  
Instrument sensitivity can vary between laboratories, and Promega Corporation recommends an 
injection time range of 3 to 22 seconds and an injection voltage range of 1 to 3 kV (Promega 
Corporation, 2011).  The six negative control samples were amplified and then electrophoresed 
at the following conditions: 1 kV for 5 seconds, 1 kV for 11 seconds, 1 kV for 22 seconds, 2 kV 
for 5 seconds, 2 kV for 11 seconds, 2 kV for 22 seconds, 3 kV for 5 seconds, 3 kV for 11 
seconds, and 3 kV for 22 seconds.   
Each set of samples were analyzed using the threshold of 1 RFU.  The highest peak height 
observed in each sample at each injection condition in all dye channels was recorded.  The data 
collected was used to determine a detection threshold on the instrumentation in conjunction with 
the PowerPlex® 16 HS system. 
Dynamic range and sensitivity. 
The previously listed DNA concentrations were also analyzed to determine the range of 
DNA concentrations that resulted in an interpretable and useable genetic profile.  To determine 
the upper limit of the dynamic range, the highest DNA concentration that resulted in a complete 
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profile was recorded after accounting for extra alleles and artifacts.  Numerous peaks such as OL 
alleles, shouldering, stutter, pull-up, minus-a artifacts, and extra peaks not related to 
amplification were accounted for and documented.  The lower limit was determined through 
analysis of low level DNA concentrations that did not result in allelic drop-out.  The sensitivity 
of the PowerPlex® 16 HS system is equivalent to the dynamic range lower limit. 
Stochastic threshold. 
To determine a stochastic threshold, peak height ratios were compared at heterozygous loci 
for the previously listed DNA samples.  The stochastic threshold represented a minimum peak 
height at which an analyst could confidently call two alleles as sister alleles.  This was extremely 
important for mixture interpretations. 
 SWGDAM recommends a general peak height ratio of < 60% is used to determine 
whether “two alleles at a heterozygous locus exhibit considerably different peak heights or an 
allele fails to amplify” (SWGDAM, 2010).  Peak height ratios were calculated by dividing the 
peak height of the lesser allele by the peak height of the greater allele and multiplied by 100. 
The stochastic threshold was determined by “plotting the peak height ratio of sister alleles 
for the sample replicates versus the lower peak height for the allelic pair at those heterozygous 
loci” (Promega Corporation, 2006).  The stochastic threshold was the peak height (RFU value) 
where a rapid drop-off in peak height ratios was observed (Promega Corporation, 2006).  This 
was a subjective value and should include a statistically significant portion of the data analyzed. 
Precision of capillary electrophoresis and reproducibility. 
The precision of the capillary electrophoresis instrument was determined by comparing 
base pair calls for a given allele.  The reproducibility was determined through comparison of 
allele calls for a particular peak’s replicated samples. 
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The reproducibility study was conducted by ensuring the same peak, following numerous 
amplification procedures and electrophoretic processes, was consistently and correctly called.  
This study was conducted by examining the electropherograms produced. 
The precision of capillary electrophoresis was conducted utilizing two different methods.  
First, the base pair call of every allele for each replicated sample of all concentrations was 
recorded.  The precision was analyzed by comparing every individual allele call of the five 
duplicated samples at each concentration.  The standard deviation was calculated for the five 
values at every allele within the genetic profile.  Second, the precision was calculated through 
comparison of the individual allele’s base pair (bp) call to the allelic ladder’s bp call.  The 
standard deviation was calculated between two bp calls.  Standards within the field accept a three 
standard deviation value less than 0.5 bp. 
Stutter rate calculations. 
 Stutter was identified as one repeat unit smaller or larger than the true allele call.  Stutter 
percentage values were determined by dividing the peak height of the stutter peak by the peak 
height of the true allele.  The analysis parameters within GeneMapper were altered to account for 
all potential stutter peaks.  Within the Analysis Method Editor, in the tab “Allele,” the “Minus 
Stutter Distance” in the “Tetra” and “Penta” columns under normal analysis conditions is “Tetra” 
from 3.25 to 4.75 and “Penta” from 3.75 to 5.75.  Both sets of data were changed to the values 
0.00 and to 0.00, which allowed all potential stutter peaks that the software cancels out to be seen 
and assessed.  The detection threshold was lowered to 25 RFU to allow stutter that may be 
masked by the threshold to be analyzed. 
A VALIDATION OF PROMEGA’S POWERPLEX® 16 HS SYSTEM  42 
The average percent of stutter at each locus was calculated.  The highest stutter peak 
observed was recorded.  A locus-by-locus stutter percentage was set due to documented 
fluctuations between the fifteen loci. 
Simulated mixture study. 
Two single source DNA samples were extracted, then combined to create the mixture 
ratios used.  The following ratios were amplified and analyzed in duplicate: 1:0, 19:1, 9:1, 4:1, 
1:1, 1:4, 1:9, 1:19, and 0:1. 
Utilizing electropherograms, the peak height ratios were calculated for all true alleles.  
Major and minor contributors were determined.  The peak height ratio was calculated as before.  
The mixture ratio was denoted as (Minor : Major).  The calculation used to determine the 
mixture ratio was the following: 
1 ∶ 	
	 	 	 	 	
	 	 	 	 	
 
The minor proportions and major proportions of mixtures were calculated as the following: 
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Mixture interpretation guidelines were established according to the results produced. 
Cross-contamination. 
A contamination study was performed to ensure no unexpected peaks were obtained on the 
instrumentation.  An injection plate was created containing a checkerboard pattern of samples 
and blanks as seen in Figures 2.3 and 2.4.  A checkerboard plate was repeated twice with an 
opposing pattern in the plate to ensure every well was analyzed for unexpected peaks that could 
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occur.  This ensures there was an absence of contamination between the samples on the Applied 
Biosystems 3130 instrument as well as the analyst and procedural methods. 
The blank wells contained the appropriate volume of ILS and formamide, and the sample 
wells contained a known amplified DNA sample.  The blank wells were examined for 
unexpected allele calls.  If an unexpected peak occurred, it was documented. 
Figure 2.3.  Checkerboard plate 1 
 1 2 3 4 5 6 7 8 9 10 11 12 
A  5  13  21  29  37  45 
B 1  9  17  25  33  41  
C  6  14  22  30  38  46 
D 2  10  18  26  34  42  
E  7  15  23  31  39  47 
F 3  11  19  27  35  43  
G  8  16  24  32  40  48 
H 4  12  20  28  36  44  
 
Figure 2.4.  Checkerboard plate 2 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1  9  17  25  33  41  
B  5  13  21  29  37  45 
C 2  10  18  26  34  42  
D  6  14  22  30  38  46 
E 3  11  19  27  35  43  
F  7  15  23  31  39  47 
G 4  12  20  28  36  44  
H  8  16  24  32  40  48 
 
Figure 2.3 and 2.4 represent the opposing checkerboard patterns that were used to fulfill the 
requirement of a contamination study.  The red wells represent the blank wells that contained 
formamide and ILS 600.  The white wells represent known amplified DNA samples. 
Mock case. 
The mock case test was conducted to ensure the protocols and instrumentation were 
functioning properly and that the correct genotypic profile was obtained.  Three samples were 
analyzed that originated from Collaborative Testing Services, Inc. (CTS) exam, test no. 10-573, 
for forensic biology.  The scenario for the test was the following: 
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The police are investigating a residential burglary.  The victim 
provided investigators with a detailed description of the individual, 
which led them to a suspect.  The suspect is a teenager that lives in 
the neighborhood.  The police recovered one questioned stain from 
the floor of the victim’s home.  The investigators are submitting 
the stains from the victim’s floor along with reference blood 
samples from the victim and suspect. 
Item 1: Known blood from the Victim 
Item 2: Known blood from the Suspect 
Item 3: Question stain from the home 
The questioned sample was analyzed first, followed by the known samples at a separate 
time and place.  At the amplification step, a positive control, negative control, and individual 
reagent blank was run for both the questioned sample and the known samples.  The questioned 
sample electropherogram was examined for unexplainable peaks observed.  Once stutter was 
filtered out of the profile, and artifacts were recognized, the allele calls were determined for each 
loci and recorded.  The known reference samples electropherograms were examined following 
completion of the questioned sample.  The known genotypes were compared to the genotype 
obtained from the questioned sample.  Known results exist for the specific case, and the results 
obtained following electrophoresis were compared for accuracy with published results by an 






Ultra Violet treatment samples. 
Five replicated DNA samples were exposed to 30, 60, 100, 200, and 300 seconds of 254 
nm ultraviolet (UV) light utilizing an AirClean 600 PCR Combination Workstation (USA 
Scientific, Ocala, FL, USA, #AC648LFUVC-43352).  This study was designed to achieve failure 
in obtaining a genetic profile.  Previous studies were examined to determine the exposure limit 
and to extend the exposed time period further than PowerPlex® 16 HS system was designed to 
endure.   
The AirClean 600 PCR Combination Workstation chamber was designed for sterilization 
of laboratory equipment, and it allowed for easy cleaning between amplification set up to limit 
contamination.  Therefore, it presented an ideal environment for the degradation of DNA 
samples in an effort to replicate degradation via sunlight through UV irradiation.   
DNA was extracted, quantified, amplified, and analyzed according to the protocols 
previously described.  Following extraction and quantification, DNA samples were placed in 
Seal-Rite 0.2 ml Indiv. Thin Wall PCR tubes with attached Dome Cap (USA Scientific, #1602-
4300).  Each tube contained 3 µl of 1 ng DNA.  Each tube was left open and exposed to the UV 
bulb for the previously stated time periods.  The tubes were located approximately 100 mm 
directly below the UV bulb on a built-in shelf within the chamber.  Figure 2.5 and 2.6 depict the 
set-up for the experiment.   
Following DNA degradation, 1.0 µl of exposed DNA samples, which were previously 
quantified at 1.0 ng, were amplified with PowerPlex® 16 HS system on a GeneAmp® PCR 
System 9700.  Capillary electrophoresis was utilized to capture the PCR fragments on an 
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Soil acid samples (tannic acid and humic acid). 
Samples were subjected to tannic and humic acid to simulate DNA samples potentially 
contaminated with PCR inhibiting soil components.  This study was designed to test the level of 
inhibition the PowerPlex® 16 HS system would withstand when analyzing a genetic profile.  
Therefore, previous studies were examined to determine the limit and to extend the 
concentrations further than the multiplexing system was designed to endure.   
One nanogram of DNA was amplified in the presence of 0 ng/µL, 50 ng/µL, 100 ng/µL, 
200 ng/µL, and 400 ng/µL concentrations of tannic and humic acids.  Each concentration for 
both potential inhibitors was repeated five times.  One microliter of humic acid and tannic acid 
for each concentration was added directly to the PCR tube.  The amount of water added to the 
PCR tube decreased by 1 µl to account for the addition.  The PCR tube was vortexed for 10 to 15 
seconds to ensure adequate mixing of the template DNA, PCR components, and potential 
inhibitor. 
A pipette and scientific balance (Sartorius, Goettingen, Germany) was used to weigh out 
tannic acid (Fisher Science Education, Hanover Park, IL, USA, #1401-55-4) and humic acid 
(Alfa Aesar, Ward Hill, MA, USA, # 1415-93-6) to construct the above mentioned 
concentrations.  Tannic acid (approximately 0.01 g) was added to 1 mL of sterile water (Fisher 
Scientific, #1609-47-8).  Humic acid (approximately 0.01 g) was added to 1 mL of sterile water.  
The tubes were vortexed for 10 to 15 seconds to ensure the solid was dissolved into the liquid.  
Both measurements formulated the highest concentration, 400 ng/µl, of the respective acids used 
to potentially simulate inhibition.  A serial dilution was made for both acids from the stock to 
formulate 200 ng/µl, 100 ng/µl, and 50 ng/µl. 
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Hematin inhibition. 
Samples were subjected to hematin to mirror inhibition of components found naturally in 
blood.  This study was designed to test the level of inhibition the PowerPlex® 16 HS system 
could withstand when analyzing a genetic profile.  Therefore, previous studies were examined to 
determine the limit and to extend the concentrations further than the multiplexing system was 
designed to endure. 
One nanogram of DNA was inhibited with the following concentrations of hematin: 0 µM, 
125 µM, 250 µM, 500 µM, and 1000 µM.  Each concentration was repeated five times.  One 
microliter of the specified hematin concentration was added directly to the appropriate PCR tube.  
The sterilized water incorporated into the PCR reaction decreased by 1 µl.  Once all components 
of the PCR process had been added, the tubes were vortexed for 10 to 15 seconds to ensure 
adequate mixing of the template DNA, PCR components, and inhibitor. 
To formulate the above listed hematin concentrations a pipette and scientific balance was 
used to weight out hematin porcine (MP Biomedicals, LLC, Solon, OH, USA, #198969).  
Hematin porcine (approximately 0.0634 g) was dissolved into 1 mL of 0.1 Normality (N) NaOH 
(Chung, 2004).  The 0.1 N NaOH was formulated by dissolving approximately 0.02 g NaOH 
(Sigma-Aldrich Inc., St.Louis, MO, USA, #221465-500G) into 5 mL of sterile water.  The initial 
stock of hematin was diluted twice to create the first concentration desired for potential 
inhibition.  Serial dilutions were made to achieve the concentrations of the desired hematin 





Limit of detection threshold. 
Six negative controls were subjected to nine varying electrophoretic conditions to analyze 
the baseline noise present on the instrumentation when using the PowerPlex® 16 HS system.  
The negative controls were analyzed under the nine conditions to ensure sufficient samples were 
evaluated to determine a minimum height that noise peaks were observed for numerous injection 
parameters.   
The raw data for the negative controls at all electrophoretic conditions are located in Table 
3.1.  Table 3.1 represents the highest detected noise peak for each replicated sample within the 
nine conditions.  As the time component increased, an increase in observable noise peak heights 
was seen.  As the injection voltage increased, an increase in observable noise peak heights 
occurred.  Table 3.2 depicts statistical information that was useful in determining a detection 
threshold effectively high enough to filter out detected noise peaks within the nine conditions.  
The data depicted in Tables 3.1 and 3.2 can be used to formulate a detection threshold at a 
second injection condition if it is deemed necessary.  SWGDAM recommends a scientific 
method be utilized to determine a threshold.  The average baseline noise plus three standard 






Table 3.1.  Highest noise peak recorded for each sample in the three dye channels that contained 
STR loci. 
 Sample Blue Green Yellow Sample Blue Green Yellow Sample Blue Green Yellow 
#1 1kV 5s 13 25 14 #1 2kV 5s 10 20 20 #1 3kV 5s 12 44 26 
#2 1kV 5s 11 18 13 #2 2kV 5s 12 39 32 #2 3kV 5s 15 37 46 
#3 1kV 5s 18 20 14 #3 2kV 5s 14 17 13 #3 3kV 5s 14 27 24 
#4 1kV 5s 16 17 17 #4 2kV 5s 13 32 27 #4 3kV 5s 13 32 30 
#5 1kV 5s 11 15 13 #5 2kV 5s 12 19 21 #5 3kV 5s 14 22 24 
#6 1kV 5s 13 18 14 #6 2kV 5s 15 20 20 #6 3kV 5s 13 40 30 
#1 1kV 11s 19 34 23 #1 2kV 11s 23 38 37 #1 3kV 11s 14 62 53 
#2 1kV 11s 12 22 18 #2 2kV 11s 12 45 39 #2 3kV 11s 15 80 66 
#3 1kV 11s 14 17 15 #3 2kV 11s 14 33 32 #3 3kV 11s 16 49 45 
#4 1kV 11s 12 19 19 #4 2kV 11s 16 31 54 #4 3kV 11s 17 95 82 
#5 1kV 11s 11 21 17 #5 2kV 11s 12 37 35 #5 3kV 11s 15 39 40 
#6 1kV 11s 15 18 14 #6 2kV 11s 15 35 22 #6 3kV 11s 14 38 31 
#1 1kV 22s 13 21 29 #1 2kV 22s 15 86 59 #1 3kV 22s 24 112 92 
#2 1kV 22s 11 36 24 #2 2kV 22s 16 96 72 #2 3kV 22s 14 111 75 
#3 1kV 22s 15 29 30 #3 2kV 22s 15 56 60 #3 3kV 22s 20 83 75 
#4 1kV 22s 16 25 18 #4 2kV 22s 19 120 115 #4 3kV 22s 25 127 116 
#5 1kV 22s 13 27 23 #5 2kV 22s 16 41 54 #5 3kV 22s 21 98 98 












Table 3.2.  Statistical calculations for determining the detection threshold for each injection 
parameters examined. 
Injection Condition Average Highest Peak Baseline w/ Average Baseline w/ Highest Peak 
      (average+3std dev) (highest peak x 2) 
1kV 5s         
blue 13.7 18 22.08094 36 
green 18.8 25 29.12411 50 
yellow 14.2 17 18.58255 34 
1kV 11s       
blue 13.8 19 22.61399 38 
green 21.8 34 40.56032 68 
yellow 17.7 23 27.27916 46 
1kV 22s       
blue 13.5 16 18.78205 32 
green 27.8 36 42.82333 72 
yellow 24.7 30 37.76628 60 
2kV 5s       
blue 12.7 15 17.92024 30 
green 24.5 39 51.11391 78 
yellow 22.2 32 41.83136 64 
2kV 11s       
blue 15.3 23 27.58078 46 
green 36.5 45 51.16629 90 
yellow 36.5 54 67.83528 108 
2kV 22s       
blue 16.7 19 22.25236 38 
green 76.3 120 164.8138 240 
yellow 70.8 115 138.2744 230 
3kV 5s       
blue 13.5 15 16.64643 30 
green 33.7 44 58.45376 88 
yellow 30 46 54.88373 92 
3kV 11s       
blue 15.2 17 18.6738 34 
green 60.5 95 129.8707 190 
yellow 52.8 82 108.5855 164 
3kV 22s       
blue 21.2 25 33.07885 50 
green 100.3 127 162.2139 254 
yellow 86 116 145.97 232 
 
Dynamic range and sensitivity. 
Fifty samples were examined to determine the DNA concentrations necessary to obtain a 
complete and useable profile compared to an incomplete and uninterruptable profile.  Following 
analysis, the samples were analyzed for known and reproducible artifacts and unexplainable 
peaks within the profile.  The dynamic range of the system was established by reviewing fifty 
known genetic profiles. 
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Table 3.3 depicts the number of alleles called correctly for each sample that was examined.  
In the larger concentrations of input DNA, unexplainable off-ladder alleles were present.  The 
5.0 ng, 2.5 ng, and 1.25 ng DNA concentrations repeatedly contained extreme levels of pull-up, 
and numerous unaccountable off-ladder alleles.  In the lower DNA concentrations, allelic 
dropout occurred at numerous loci, which affected the ability of the profile to be interpreted 
correctly.  Allelic dropout was first observed at the larger loci analyzed within the 0.08 ng DNA 
samples.  The sensitivity of the system is equivalent to the lower limit of the dynamic range.  The 
data supports a confident dynamic range of 0.63 ng to 0.16 ng of DNA to produce an 
interpretable and explainable genetic profile.  A concentration of 1.0 ng of DNA may be utilized 
with caution due to the potential for pull-up and additional alleles.  The sensitivity of the system 
is 0.16 ng of DNA.  Lower DNA concentrations should be used with caution due to extreme 
allelic dropout observed. 
Table 3.3.  Correct number of allele calls for the DNA concentrations examined for the dynamic 
range and sensitivity studies. 
Total Conc. of 
Input 
DNA/Sample 5.0ng 2.5ng 1.25ng .63ng .31ng .16ng .08ng .04ng .02ng .01ng 
FTA1 29/29 29/29 29/29 29/29 29/29 29/29 20/29 14/29 4/29 0/29 
FTA2 29/29 29/29 29/29 29/29 29/29 29/29 27/29 20/29 5/29 5/29 
FTA3 29/29 29/29 29/29 29/29 29/29 29/29 22/29 19/29 0/29 0/29 
FTA4 29/29 29/29 29/29 29/29 29/29 29/29 27/29 22/29 3/29 3/29 
FTA10 29/29 29/29 29/29 29/29 29/29 29/29 26/29 14/29 0/29 0/29 
Note: denotes numerous OL alleles, pull-up, shouldering, minus-a, and stutter artifacts that 
render the profiles un-interpretable; represented useable and interpretable DNA profiles that 
were examined; allele dropout was present which affected the ability to interpret the profile. 
Stochastic threshold. 
The stochastic threshold is “a value above which it is reasonable to assume that allelic 
dropout has not occurred within a single-source sample” (SWGDAM, 2010).  The field has 
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determined an analyst can confidently interpret two alleles at a heterozygote locus to be sister 
alleles if their peak height ratio exceeds 60%.  SWGDAM interpretation guidelines set a 60% 
general peak height ratio for sister alleles at heterozygous locus. 
During analysis of single source samples, numerous sister alleles at heterozygous loci do 
not possess a peak height ratio above 60%.  The peak height ratios for thirteen heterozygous loci 
of a single-source sample are displayed in Table 3.4.  The percentages observed below the 
recommended 60% are highlighted in red within Table 3.4.  This is problematic due to the 
assumption that sister alleles at a heterozygous locus in a single-source sample have generally 
comparable peak heights.  A problematic situation for interpretation arises due to sister alleles 
possessing a 30% peak height ratio. 
Figure 3.1 displays the peak height ratio percentage compared to the lowest RFU value 
associated with the percent.  Figure 3.1 was used to determine the potential threshold values and 
percent of the data included.  A threshold was established at a location where the majority of the 
data was included with respect to a value most data could be analyzed against.   
A subjective threshold at which 97.44% of the data was within the threshold.  Five outliers 
were present within the viable range of 195 data points.  The stochastic threshold for this system 
was set at 750 RFU.  The stochastic threshold can be increased to 900 RFU, which would 
include 191 data points out of 195 total data points.  This includes 97.95% of the viable range.  
An analysis of setting the threshold at 1300 RFU, lead to 98.97% of the data incorporated within 





Table 3.4.  Peak Height Ratios 
  D3 TH01 D21 D18 PentaE D5 D13 D7 D16 CSF PentaD Amel vWA D8 TPOX FGA 
0.63 
FTA1 98.24% 81.26% 90.60% 72.72% 80.82% 71.01% 98.34%   86.58%   53.96%   59.94% 92.14% 80.97% 77.60% 
0.63 
FTA2 77.23% 98.29% 94.96% 76.78% 82.58% 67.14% 96.73%   80.55%   82.61%   66.62% 46.06% 99.10% 80.25% 
0.63 
FTA3 84.21% 86.07% 82.43% 94.35% 95.14% 92.55% 95.48%   94.88%   81.96%   95.13% 50.22% 69.28% 99.18% 
0.63 
FTA4 96.13% 99.69% 85.02% 80.81% 92.64% 82.60% 90.96%   82.51%   77.73%   87.59% 75.82% 98.27% 81.79% 
0.63 
FTA10 82.71% 90.44% 92.75% 85.83% 92.96% 72.83% 87.46%   87.08%   99.85%   83.06% 43.69% 83.62% 95.08% 
                                  
0.31 
FTA1 81.38% 97.91% 89.59% 95.12% 66.79% 72.74% 99.15%   95.33%   94.10%   91.85% 72.23% 78.28% 76.42% 
0.31 
FTA2 79.38% 77.05% 87.38% 99.57% 69.97% 67.90% 86.07%   84.59%   90.98%   98.49% 59.34% 80.46% 79.31% 
0.31 
FTA3 72.21% 76.66% 76.19% 61.96% 74.54% 77.36% 73.79%   89.01%   95.05%   94.74% 49.78% 55.74% 100% 
0.31 
FTA4 96.37% 83.20% 79.73% 47.01% 58.71% 84.92% 83.50%   82.01%   65.79%   96.98% 48.17% 52.38% 78.04% 
0.31 
FTA10 94.83% 98.46% 97.00% 64.55% 91.26% 91.20% 78.02%   98.66%   78.52%   84.82% 30.31% 60.27% 86.22% 
                                  
0.16 
FTA1 67.97% 73.48% 64.65% 42.11% 65.31% 52.08% 95.14%   86.33%   72.39%   74.92% 66.23% 65.89% 49.34% 
0.16 
FTA2 66.48% 96.62% 95.73% 92.27% 47.32% 58.08% 61.97%   58.68%   81.48%   56.01% 82.58% 86.17% 65.60% 
0.16 
FTA3 82.56% 77.98% 51.17% 83.92% 98.76% 49.03% 82.99%   85.67%   58.77%   77.97% 94.68% 59.85% 63.48% 
0.16 
FTA4 70.47% 74.44% 83.30% 65.17% 53.23% 99.26% 54.63%   62.32%   94.14%   77.20% 90.49% 89.62% 80.55% 
0.16 














Figure 3.1.  Stochastic Threshold 
 
Figure 3.1.  The figure represents the peak height ratio of sister alleles at a heterozygous loci on 
the y-axis and the lowest peak height associated with the  ratio on the x-axis (Promega 
Corporation, 2006).  A total of 195 data points were included in this analysis.  The five 
highlighted values represent the outliers that were not included in the 750 RFU stochastic 
threshold. 
Precision of capillary electrophoresis and reproducibility. 
The precision and reproducibility study analyzed three concentrations of DNA within the 
dynamic range to ensure each known profile was called correctly.  As DNA fragments move 
through the capillary they are detected in a bell-curve pattern.  The sloping sides of the bell curve 
represent 	3 standard deviations of the DNA.  Reproducibility ensures that every time a sample 
is analyzed it is called the same in a genetic profile.  Precision examines whether the base pair 
calls are within the 0.5 base pair bin in the allelic ladder. 
The five replicated samples base pair calls for every allele within the dynamic range were 


































multiplexing systems.  The first included comparing the replicated samples to each other.  The 
second compared individual samples to the allelic ladder they were simultaneously analyzed 
with.  To ensure every DNA fragment is within the 0.5 bp allotted bin as they migrate through 
the capillary, three standard deviations of the replicated samples were calculated and compared 
to each other.  The standard deviation of the five replicated samples for each allele at the loci 
examined is depicted in Table 3.5.  One allele did not meet the required value of < 0.5 bp, which 
is highlighted in red in Table 3.5.  The standard deviation was multiplied by three and analyzed 
against the 0.5 bp value set as a standard for precision of an instrument.  This was problematic 
for the precision study; however, the allele in question was reported as the correct allele every 
time it was analyzed.   
The second method included comparing an individual allele call to the allelic ladder.  
When the five replicates of the problematic allele were individually compared to the concurrent 
allelic ladders they were analyzed with, each allele was significantly lower than 0.5 bp value 
required.  Table 3.6 shows the statistical data for comparison of the allele that did not produce a 
precision bp value < 0.5 bp when compared to its replicates.  When the individual samples were 
compared to the simultaneously analyzed allelic ladders, each sample was less than 0.5 bp as 
seen in Table 3.6.  Various studies have utilized both methods to examine precision.   
Through all phases of the validation study the DNA profiles were compared to known 
profiles for the corresponding sample. The reproducibility of each sample proved consistent 





Table 3.5.  Standard Deviation of Base Pair Calls 
D3S1358   TH01   D21S11   D18S51   PentaE   D5S818   D13S317   D7S820 
Std Dev 
of 0.63ng 15 0.14007 7 0.11261 29 0.14467 18 0.11349 7 0.14107 10 0.14967 12 0.12341 12 0.12582 
16 0.13353 8 0.12194 32.2 0.14673 20 0.11925 13 0.13882 11 0.16407 13 0.12872     
Std Dev 
of 0.31ng 15 0.14755 7 0.11023 29 0.15116 18 0.11 7 0.13038 10 0.1589 12 0.11437 12 0.09407 
16 0.15515 8 0.12116 32.2 0.11653 20 0.11971 13 0.08468 11 0.18158 13 0.10334     
Std Dev 
of 0.16ng 15 0.13134 7 0.11502 29 0.14822 18 0.1161 7 0.11212 10 0.15073 12 0.139 12 0.11887 
16 0.1333 8 0.12317 32.2 0.13502 20 0.11189 13 0.10035 11 0.14923 13 0.10502     
 
  D16S539   CSF1PO   PentaD   Amel.   vWA   D8S1179   TPOX   FGA 
Std Dev 
of 0.63ng 11 0.10464 10 0.09381 11 0.11987 X 0.00837 15 0.03421 12 0.04159 7 0.03362 21 0.06914 
13 0.09263     12 0.11632     18 0.04266 17 0.06892 8 0.02966 23 0.04899 
Std Dev 
of 0.31ng 11 0.06782 10 0.11874 11 0.11238 X 0.03 15 0.02702 12 0.0658 7 0.02739 21 0.05788 
13 0.08408     12 0.10464     18 0.02702 17 0.04669 8 0.03209 23 0.0497 
Std Dev 
of 0.16ng 11 0.07861 10 0.06245 11 0.1494 X 0.04528 15 0.02074 12 0.06841 7 0.03742 21 0.04879 




















Call Std Dev 3*Std Dev 
0.31 FTA2 10 123.83 10 0.066833 0.20049938 
  11 128.03 11 0.044347 0.13304135 
Allelic Ladder 10 123.98 
  11 128.11 
Allelic 
Ladder2 10 123.85 
  11 128.01 
Allelic 
Ladder3 10 123.9 
  11 128.03 
0.31 FTA10 10 123.99 10 0.091924 0.27577164 
  11 128.28 11 0.021213 0.06363961 
Allelic Ladder 10 124.12 
  11 128.25 
0.31 FTA4 10 124.15 10 0.055076 0.16522712 
  11 128.39 11 0.025166 0.07549834 
Allelic Ladder 10 124.26 
  11 128.37 
Allelic 
Ladder2 10 124.2 
  11 128.34 
0.31 FTA3 10 123.82 10 0.06994 0.20982135 
  11 128.03 11 0.044347 0.13304135 
Allelic Ladder 10 123.98 
  11 128.11 
Allelic 
Ladder2 10 123.85 
  11 128.01 
Allelic 
Ladder3 10 123.9 
  11 128.03 
0.31 FTA1 10 123.76 10 0.09215 0.27645072 
  11 127.98 11 0.055603 0.16680827 
Allelic Ladder 10 123.98 
  11 128.11 
Allelic 
Ladder2 10 123.85 
  11 128.01 
Allelic 
Ladder3 10 123.9 
  11 128.03 
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Stutter rate. 
A stutter study was conducted to document observed stutter within the dynamic range.  
Elevated stutter and n+4 stutter was revealed within the dynamic range.  Stutter was 
distinguished as a peak one repeat unit below a true allele, and on occasion one repeat unit above 
an allele.  
Stutter was evaluated on a locus-by-locus condition due to the fluctuation of stutter 
percentages within the 15 loci examined.  Amelogenin was not observed to have stutter.  The 
average stutter plus three standard deviations was compared to the highest recorded stutter value.  
They were evaluated to formulate a conservative stutter ratio for every locus.  Stutter values for 
tetra-nucleotide repeats are normally less than 10% of the true allele peak (Walsh et al., 1996).  
After consideration, the highest stutter value was used to formulate the marker specific stutter 
ratio.  The values chosen to represent stutter ratios for each loci are located in Figure 3.2. 
 When the dynamic range was analyzed for stutter artifacts, loci were observed to possess 
outlying stutter peaks.  The stutter data analyzed is depicted in Table 3.7.  Table 3.7 lists the 
average stutter seen at each locus, the standard deviation of stutter at each locus, the highest 
stutter percent seen at each locus, and an outlier if present at each locus.  The marker specific 
stutter ratio represent the value stutter will be held to during interpretation of profiles.  The 
outlying stutter peaks were not observed more than once; therefore, it is recognized they did 
occur but were not detected again.  The outlying stutter peaks were not used in determining a 





Figure 3.2.  Marker Specific Stutter Ratios 
 
Figure 3.2 indicates stutter percent values that were evaluated and applied to each locus during 
interpretation. 
















D3S1358 9.45 2.4762875 16.87886 11.6 
  12 
TH01 2.9714286 1.405171 7.186942 7.4 
  8 
D21S11 8.825641 3.1209578 18.188515 16.9 
  17 
D18S51 10.534286 4.4047396 23.748505 17.6 
  18 
PentaE 3.9818182 1.2536492 7.742766 5.3 
  6 
D5S818 8.89 3.8670833 20.49125 17.7 
  18 
D13S317 10.033333 6.1749108 28.55807 18.8 
25.9 19 
D7S820 5.375 3.2054286 14.99129 10.6 
  11 
D16S539 9.5466667 3.3052449 19.462401 13.2 
20.5 14 
CSF1PO 4.9 1.4383633 9.21509 6.2 
  7 
PentaD 4.075 3.7579915 15.34897 9.5 
  10 
vWA 10.328125 5.9085086 28.053651 18.9 
31.4 19 
D8S1179 7.6964286 6.2408144 26.418872 12.5 
35.4 13 
TPOX 1.6 0.0707107 1.812132 1.7 
  2 




























Simulated mixture study. 
A mixture study was performed on two single-source blood samples.  Two person mixtures 
were obtained in every ratio.  This was interpreted as at least three alleles present at a locus 
within the profile.   
The complete genetic profile for the major and minor contributor were present within the 
1:1 and 4:1 samples.  The 1:4 mixture ratio experienced minor allele dropout for the minor 
contributor.  The mixture ratios of 19:1, 1:19, 9:1, and 1:9 saw allele dropout at numerous loci 
for the minor contributor. 
The observable and calculable differences in peak heights at loci were analyzed.  Peak 
height ratios were calculated for all alleles present at a specific locus.  The minor contributor’s 
percent was determined at a locus possessing four allele calls.  When a contributor’s percent was 
applied to other loci within the genetic profile, wrong allele calls were attributed to the suspected 
contributor.  In a major and minor contribution scenario, the quantity of one contributor should 
be imbalanced compared  to the second contributor.  However, when the mixture samples were 
analyzed with PowerPlex® 16 HS system the result was an indistinguishable mixture.  The 
majority of the peaks presented similar peak heights.  Therefore, an allele could not be 
contributed to a specific individual with any certainty. 
Cross-contamination. 
A checkerboard pattern was run to ensure contamination did not occur between wells on 
the Applied Biosystems 3130 Genetic Analyzer.  Nine off-ladder (OL) alleles were present 
within the 96 blank wells that were examined.  The OL alleles were not present within the bins 
for the specific loci.  The peak heights and location of the OL alleles are shown in Table 3.8.  
The OL alleles were not present within a bin located in the allelic ladder.  The OL peaks did not 
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repeat throughout the entire 96-well plate.  Therefore, it was determined no potentially harmful 
carry over existed between the wells.   
Table 3.8.  Contamination Study Off-ladder Alleles 
Sample Name/Plate 
No. 
RFU value, bp call Location 
1MF/Plate 1 108RFU, 399.91bp middle of FGA 
3MF/ Plate 1 97RFU, 299.92bp between TPOX & 
FGA 
3MF/ Plate 1 112RFU, 399.91bp middle of FGA 
9MF/ Plate 1 99RFU, 399.83bp middle of FGA 
17MF/ Plate 1 95RFU, 299.92bp between TPOX & 
FGA 
17MF/ Plate 1 98RFU, 399.91bp middle of FGA 
27MF/ Plate 1 96RFU, 399.91bp middle of FGA 
10MF/ Plate 2 175RFU, 258.85bp between D7 & D16 




A mock case exam was performed on previously prepared samples to ensure the proper 
genetic profile was obtained from testing.  One questioned sample was tested, followed by two 
known reference samples.  The genotypes obtained are listed in Table 3.9.  The positive controls, 
negative controls, and reagent blanks all performed as expected with no unwarranted peaks.  The 
profiles contained correct allele calls when compared to known genotypes for the samples.  The 
results were confirmed by an independent and known reviewer.  The correct results for the mock 
case exam are displayed in the appendix, Figure A. 
Table 3.9.  Mock Case Results 
Sample 
tested D3 TH01 D21 D18 PentaE D5 D13 D7 D16 CSF1P0 PentaD Amel vWA D8 TPOX FGA 
Q1 17,18 7,8 28,32.2 15 12,16 8,11 11,12 9,11 11,12 12 5,8 X,Y 18,19 13,14 8 19,22 
K1 14,17 9.3 29,31.2 12 5,17 10,13 11,12 11 9,12 11,12 8,13 X 16,18 12,15 8 19,23 






A UV treatment study was conducted to test the limit at which DNA would fail 
amplification.  The amount of correctly called alleles decreased as the exposure time of UV light 
increased as seen in Table 3.10.  A full genetic profile was detected with repeated samples 
exposed to 30 seconds of UV light at a distance of 100 mm.  Within in the five replicates 
exposed to 60 seconds of UV light the peak height values decreased significantly.  This pattern 
was observed throughout the study as exposure time increased.  D18S51, Penta E, CSF1P0, 
Penta D, D8S1179, TPOX, and FGA repeatedly dropped-out of the genetic profile after 
sustaining 60+ seconds of exposure to UV light.  At 200 seconds, seven alleles were called with 
peak heights ranging from 200 to 500 RFU.  Loci D3S1358, D21S11, and vWA were correctly 
called in every sample at every exposed time period.  TH01 and Amelogenin were called 
correctly for all samples at every exposed time except two.  An electropherogram for each UV 
exposure time is located in the appendix in Figures B-F. 














0sec-1 29/29 60sec-1 24/29 200sec-1 8/29 
0sec-2 29/29 60sec-2 22/29 200sec-2 9/29 
0sec-3 29/29 60sec-3 20/29 200sec-3 8/29 
0sec-4 29/29 60sec-4 19/29 200sec-4 10/29 
0sec-5 29/29 60sec-5 21/29 200sec-5 8/29 
30sec-1 29/29 100sec-1 19/29 300sec-1 8/29 
30sec-2 29/29 100sec-2 12/29 300sec-2 7/29 
30sec-3 29/29 100sec-3 16/29 300sec-3 7/29 
30sec-4 29/29 100sec-4 17/29 300sec-4 7/29 
30sec-5 28/29 100sec-5 16/29 300sec-5 7/29 
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Tannic acid. 
 A study was conducted to test the limit at which DNA would fail to amplify due to 
inhibition in the PCR process caused by tannic acid.  As the concentration of tannic acid 
increased, the number of alleles called decreased as seen in Table 3.11.  The PowerPlex® 16 HS 
system was able to withstand relatively high concentrations of tannic acid added directly to the 
PCR tube.  All alleles were called correctly after an inhibition of 50 ng/µl; however, the peak 
height dropped at every loci compared to peak heights observed with no inhibition.  Tolerance 
for inhibition rapidly dropped off between 50 ng/µl to 100 ng/µl.  An electropherogram for each 
tannic acid concentrations is depicted in the appendix Figures G-J. 














0ng/µl-1 29/29 100ng/µl-1 4/29 400ng/µl-1 0/29 
0ng/µl-2 29/29 100ng/µl-2 4/29 400ng/µl-2 0/29 
0ng/µl-3 29/29 100ng/µl-3 6/29 400ng/µl-3 0/29 
0ng/µl-4 29/29 100ng/µl-4 4/29 400ng/µl-4 0/29 
0ng/µl-5 29/29 100ng/µl-5 4/29 400ng/µl-5 0/29 
50ng/µl-1 29/29 200ng/µl-1 0/29 
50ng/µl-2 29/29 200ng/µl-2 0/29 
50ng/µl-3 29/29 200ng/µl-3 0/29 
50ng/µl-4 29/29 200ng/µl-4 0/29 
50ng/µl-5 29/29 200ng/µl-5 0/29 
 
Humic acid. 
A study was conducted to test the limit of humic acid inhibition.  As the concentration of 
humic acid increased within the PCR reaction, fewer alleles were present within the genetic 
profile as seen in Table 3.12.  Intermediate amounts of humic acid led to larger loci dropping out, 
with smaller loci still amplifying.  The PowerPlex® 16 HS system showed tolerance with humic 
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acid inhibition with numerous alleles amplifying despite 100 ng/µl inhibition.  An 
electropherogram for each inhibited concentration is located in the appendices, Figures K-N. 














0ng/µl-1 29/29 100ng/µl-1 16/29 400ng/µl-1 0/29 
0ng/µl-2 29/29 100ng/µl-2 17/29 400ng/µl-2 0/29 
0ng/µl-3 29/29 100ng/µl-3 19/29 400ng/µl-3 0/29 
0ng/µl-4 29/29 100ng/µl-4 18/29 400ng/µl-4 0/29 
0ng/µl-5 29/29 100ng/µl-5 5/29 400ng/µl-5 0/29 
50ng/µl-1 29/29 200ng/µl-1 0/29 
50ng/µl-2 29/29 200ng/µl-2 0/29 
50ng/µl-3 29/29 200ng/µl-3 0/29 
50ng/µl-4 29/29 200ng/µl-4 0/29 
50ng/µl-5 29/29 200ng/µl-5 0/29 
 
Hematin. 
A study was conducted to test the limit at which a concentration of hematin completely 
inhibited the PCR process.  The initial concentrations of hematin did not inhibit the profile; 
however, when an apparent threshold of 1000 µM was added to the PCR process, the entire 
genetic profile dropped out.  PowerPlex® 16 HS system withstood a great deal of inhibition.  
Table 3.13 depicts the number of correctly called alleles for the various hematin concentrations 
tested.  Electropherograms for the hematin concentrations used to inhibit the PCR process are 



















0µM-1 29/29 250µM-1 29/29 1000µM-1 0/29 
0µM-2 29/29 250µM-2 29/29 1000µM-2 0/29 
0µM-3 29/29 250µM-3 29/29 1000µM-3 0/29 
0µM-4 29/29 250µM-4 29/29 1000µM-4 0/29 
0µM-5 29/29 250µM-5 29/29 1000µM-5 0/29 
125µM-1 29/29 500µM-1 29/29 2000µM-1 0/29 
125µM-2 29/29 500µM-2 29/29 4000µM-1 0/29 
125µM-3 29/29 500µM-3 29/29 
125µM-4 29/29 500µM-4 29/29 






Limit of detection threshold. 
A conservative detection threshold was set to ensure all background noise would be 
filtered out of genetic profiles for interpretation.  When setting a high detection threshold, the 
ability to lose allelic data is an important consideration.  SWGDAM interpretation guidelines 
recommend a laboratory “establish an analytical threshold based on signal-to-noise analyses of 
internally derived empirical data through scientific methods” (SWGDAM, 2010).  Promega 
Corporation recommends 3 kV and 5 seconds as the optimal electrophoretic condition with 0.5 to 
1.0 ng of template DNA.  Numerous methods were executed in order to evaluate the most 
conservative threshold value that could be set to reliably distinguish noise from true peaks.  
The electrophoretic condition of 3 kV and 5 seconds was chosen for analysis.  Within the 
yellow channel the largest noise peak was observed at 46 RFU.  The largest noise peak seen in 
the blue channel was 15 RFU and in the green channel was 44 RFU.  The value of 46 RFU was 
the largest noise peak observed in all six samples within 3 kV and 5 seconds.  To effectively set a 
conservative threshold, the 46 RFU value was doubled and rounded up to produce a value of 95 
RFU.  The baseline average plus three standard deviations produced a rounded value of 60 RFU.  
After comparing the two values, a conservative and subjective detection threshold was 
established at 95 RFU.  As more data is collected and analyzed, the detection threshold can be 
reexamined and re-established. 
Within the developmental validation of the PowerPlex® 16 HS system, a calling threshold 
of 50 RFU was used (Ensenberger et al., 2010).  The value for peak detection threshold usually 
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ranges from 50-150 RFU (Promega Corporation, 2011).  Therefore, an allele call should 
confidently be recognized as a true allele with a detection threshold set at 95 RFU. 
Dynamic range and sensitivity. 
The dynamic range and sensitivity studies were conducted to establish a consistent usable 
range of DNA concentrations for amplification that resulted in the highest quality data output 
following capillary electrophoresis.  Forensic DNA typing utilizes PCR and electrophoretic 
technology, which may result in data originating from locations other than the sample 
(SWGDAM, 2010).  It is necessary for interpretation procedures to attempt to limit prospective 
non-allelic peaks from being observed (SWGDAM, 2010). 
Non-allelic peaks were observed in the 5.0 ng, 2.5 ng, and 1.25 ng DNA concentrations.  
In higher concentrations, large amounts of stutter were observed, as well as other artifacts, non-
specific amplification product, and instrumental limitations.  Most resulted from pull-up due to 
off-scale data in an adjacent channel; however, some OL alleles could not be explained.  The 
PowerPlex® 16 HS system technical manual states samples may show low level artifacts 
between particular loci, OL artifacts can be seen in the 690 to 691 bp position, and one or more 
extra peaks have been observed in certain loci that are not related to amplification (Promega 
Corporation, 2011).  Extra peaks not related to amplification were largely present within the 
TH01 locus.  High amounts of template DNA, or poor quality formamide, polymer, and 
capillaries can cause the extra unexplained peaks to exist (Promega Corporation, 2011).  This 
causes a problem during interpretation of a genetic profile; therefore, the 5.0 ng, 2.5 ng, and 1.25 
ng DNA concentrations were not included in the dynamic range.  Extreme caution should be 
taken when DNA samples of 1.0 ng or higher are used.   
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Beginning with 0.08 ng of DNA, allelic dropout was seen in the replicated samples at the 
larger loci.  The 0.04 ng, 0.02 ng, and 0.01 ng samples did experience dramatic allelic dropout or 
complete dropout at all 16 loci analyzed.  Allelic dropout hinders the ability to interpret genetic 
profiles correctly; therefore the 0.08 ng, 0.04 ng, 0.02 ng, and 0.01 ng of DNA concentrations 
were not included in the dynamic range.  The sensitivity was determined to be 0.16 ng of DNA.  
Extreme caution should be used when concentrations below 0.16 ng are used due to expected 
allelic dropout.   
The dynamic range was determined to be 0.63 ng to 0.16 ng of DNA.  The recommended 
amplification concentration of template DNA is 0.5 ng in a 25 µl reaction volume for 3 kV and 5 
second parameters (Promega Corporation, 2011).  Promega also states, “with >1 ng of DNA, 
preferential amplification of smaller loci may occur” (Promega Corporation, 2011).  Therefore, 
the dynamic range that was determined is in accordance with the manufacturer recommended 
concentrations existing within the range of DNA that was determined applicable on the 
instrumentation for the established parameter used. 
Stochastic threshold. 
SWGDAM has set interpretation guidelines that are used by the field.  In SWGDAM’s 
guidelines, section three addresses “Interpretation of DNA Typing Results” (SWGDAM, 2010).  
Under “Application of Peak Height Thresholds to Allelic Peaks” (guideline 3.2), stochastic 
thresholds are addressed (SWGDAM, 2010).  A general peak height ratio of 60% is used to 
determine whether “two alleles at a heterozygous locus exhibit considerably different peak 
heights or an allele fails to amplify” (SWGDAM, 2010).  A peak height ratio larger than 60% 
increases the statistical likelihood that the peaks originated from a single-source.   
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A peak height ratio of 60% was used to determine the stochastic threshold.  However, due 
to the extreme peak height imbalances observed between known sister alleles determining a 
reasonable stochastic threshold was unlikely.  A 750 RFU threshold value was determined to be 
the most practical stochastic threshold.  Five of 195 data points were considered outliers with a 
750 RFU threshold.  A stochastic threshold of 750 RFU represents 97.44% of the viable range.  
Due to the extreme level of peak height imbalance, the stochastic threshold is not a reliable tool 
for use in convoluted interpretations.  
The stochastic threshold plays a large role in determining mixture ratios within a genetic 
profile.  Ideally, sister alleles should have balanced peak heights, which allow comparisons to be 
made in a major/minor situation.  Sister alleles do not possess balanced peak heights at 
heterozygous loci when analyzed with the PowerPlex® 16 HS system.  A stochastic threshold set 
at 750 RFU is problematic for low-template DNA samples.  Most low-template DNA samples 
will not have peak heights larger than 750 RFU; therefore, the loci that do not exceed 750 RFU 
cannot be interpreted for potential mixture deconvolution.  More investigation into this area is 
needed to explore the effect of various amplification cycles and electrophoretic parameters on 
peak height ratios and establishment of a stochastic threshold. 
The PowerPlex® 16 HS System technical manual addresses ways to troubleshoot peak 
height imbalance.  One cause is the amplification of  > 1.0 ng of template DNA.  This is resolved 
by decreasing the template DNA or decreasing the amplification cycles used.  The use of FTA® 
paper, degraded DNA samples, and insufficient template DNA cause peak height imbalance.  It 
should be mentioned, whole blood and blood samples on FTA® cards were extracted and used 
throughout this research.  One did not provide a better balance in peak heights compared to the 
other.  DNA concentrations under 1.0 ng were utilized as well which did not result in peak height 
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balance.  The stochastic threshold should not be the only interpretation guideline that is taken 
into account when dealing with a convoluted situation.     
Precision of capillary electrophoresis and reproducibility. 
Precision and reproducibility are a large component within the validation study.  The 
assurance that an allele will be called correctly every time it is analyzed is a large element of 
withstanding scrutiny in court.  This study was analyzed through comparing allele calls and base 
pair calls of alleles. 
Two methods have been established to examine the precision of the instrument.  One 
method compares the individual allele’s base pairs to the allelic ladder, while the second 
compares replicates of the allele’s base pairs.  An allele is called based on the allelic ladder; 
however, just because an allele is called correctly, three standard deviations of the DNA base 
pairs may not fall perfectly within the assigned bin of the allelic ladder.  Depending on the 
electrophoretic conditions, the migrating DNA may not produce a normal bell curve distribution. 
Unexpectedly, when both methods were used to examine precision, two different outcomes 
were observed.  One allele out of eighty-seven did not achieve a precision value of less than 0.5 
bp that the field has established as the standard when comparing the replicates to one another.  
However, when the five replicated samples were analyzed to the simultaneous allelic ladders, 
each allele was less than 0.5 bp. 
This has an effect on interpretation of genetic profiles.  It was estimated that an allele could 
potentially fall outside of its allotted window, which would result in an incorrect allele call being 
made.  However, every time this allele was analyzed it was called correctly. 
The precision situation that arose cannot be ignored.  However, the reproducibility of the 
entire study did not encounter any issues of mislabeled alleles.  No evidence exists within 
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documented validation studies of the PowerPlex® 16 HS system that indicates this issue has 
occurred previously.  As more samples are collected and more data are analyzed, the precision of 
the multiplexing system should be revisited. 
Stutter rate. 
Elevated levels of stutter were present during the study.  Parameters were altered to 
account for all potential stutter peaks that could be observed.  Stutter was evaluated on a locus by 
locus situation.  The overall average of stutter present at each locus closely paralleled the average 
stutter rates that were seen during the developmental validation.  A locus specific percentage was 
used to determine a stutter percentage for each locus analyzed.  Due to the variability in stutter 
percentages, a flat percentage would not adequately benefit the analyst during interpretation.   
The marker specific stutter ratio used for each locus represents a conservative percentage.  
Following an evaluation of three standard deviations plus the average stutter values compared to 
the highest stutter value, the highest stutter value produced the most cautious values for 
interpretation support. 
Due to outliers present within the data, the stutter percentages should only be used to assist 
when interpreting genetic profiles.  The validation study was performed on 32 cycles of 
amplification.  Thermal cycle procedures affect stutter that is present within genotypes.  A 
validation study is recommended to be performed at 30 amplification cycles in an effort to 
decrease the amount of stutter that was present within the dynamic range.  As more samples are 
examined and data is collected genetic profiles should continually be examined for high stutter 
peaks present. 
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Simulated mixture study. 
Numerous methods exist for deconvoluting a mixture.  The mixture samples were 
interpreted for assignment of a major and minor contributor.  However, due to imbalanced peak 
height ratios this became an unachievable task for interpretation procedures.  Due to peak height 
differences observed between sister alleles, interpretation of data past a single-source profile is 
not recommended.  The PowerPlex® 16 HS system does not meet the necessary requirements to 
interpret mixture profiles to a statistical certainty.  The peak height ratio imbalance seen in sister 
alleles creates a difficult scenario to correctly assign the genotypes at a locus with multiple 
alleles where all the alleles have similar peak heights.   
 The classic analytical procedures to interpret DNA mixture samples broke down at equal 
concentrations of DNA and unequal concentrations of DNA.  Mixture ratios of 4:1 and 1:4 
should be distinguishable due to unequal representation within the sample.  However, the 
PowerPlex® 16 HS system could not differentiate the two contributing DNA profiles.   
Cross-contamination. 
The contamination study is intended to prove no carry-over exists between the four 
capillaries within the Applied Biosystems 3130 Genetic Analyzer.  Contamination is not 
expected to occur due to the numerous wash and rinse steps the machine performs between 
sample injections. The wash and rinse steps that were performed before, between, and after each 
samples injection are designed to prevent contamination.  The nine OL alleles that were present 
within the blank wells were not located within the bins designed to call true alleles.  It is more 
likely that due to a lack of consistent performance on the Applied Biosystems 3130 Genetic 
Analyzer, non-reproducible artifacts such as bubbles or urea crystals built up and were moved 
through the capillary as injections were run on the instrument.  The OL alleles were not present 
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in every negative control that was analyzed; therefore, it was not a reproducible artifact.  Extra 
peaks may be visible within the green dye color due to contaminated water used to dilute 10X 
Buffer and fill the wash and rinse buffer reservoir (Promega Corporation, 2011).  After analysis, 
the OL alleles that were present do not pose a threat of contamination within the instrument.  
Mock case. 
The results were treated in a casework manner.  Following analysis of the questioned 
sample and known samples, the genetic profiles obtained were all correctly identified with 
known results by an independent reviewer.  No unexpected occurrences were encountered during 
the laboratory testing and interpretation process.  All alleles were present following 
interpretation of known artifacts.  All controls performed as expected.   
Environmental Inhibitors 
The PowerPlex® 16 HS system withstood known environmental inhibitors with a great 
deal of tolerance.  Extreme amounts of inhibitors caused the PCR process to fail and severely 
degrade DNA fragments.  However, intermediate ranges of inhibitors were overcome using the 
PowerPlex® 16 HS system.  The extreme amounts of inhibitors would most likely not be seen in 
casework samples due their excessive nature.  No effort was made to overcome the effect of 
inhibition in the samples.  Bovine serum albumin (BSA) was not added to the samples to help 
alleviate the inhibitors dramatic effect on the PCR process.  The multiplexing system proved it is 
capable of handling forensic samples that may be subjected to the four inhibitors examined.   
UV treatment. 
The PowerPlex® 16 HS system endured a great deal of degradation caused by UV 
irradiation applied directly to the DNA samples.  The color of the DNA samples did not change 
following degradation.  Peak heights at all loci examined decreased between 30 seconds of 
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exposure to 60 seconds of exposure.  Due to degradation caused by prolonged exposure to UV 
irradiation, only small PCR products were able to amplify.  The amplicon size of D3S1358, 
TH01, D21S11, and vWA proved an effective tool at overcoming DNA degradation.  No dropout 
was seen at the previously mentioned loci.  Allelic dropout was seen between 332 bp and 415 bp 
at 60 seconds of exposure, and amongst 289 bp and 415 bp at 100 seconds.  Increased allelic 
dropout occurred from 128 bp to 415 bp at 200 and 300 seconds of degradation.   UV irradiation 
simulates sunlight exposure to DNA samples; however, the intensity and close proximity of the 
samples to the source of degradation in this research to simulated only the most intense 
inhibition potentially seen in casework. 
Tannic acid and humic acid. 
The PowerPlex® 16 HS system demonstrated tolerance with both tannic acid and humic 
acid.  Identical concentrations at each inhibitor were added to the PCR tubes to examine potential 
inhibition that could occur.  Both inhibitors resulted in complete profile drop-out at 200 ng/µl 
and 400 ng/µl.  The coloration of tannic acid was less pronounced compared to humic acid.  
Tannic acid produced a slightly enhanced yellow tint; whereas, humic acid displayed a black 
coloration.  A photograph of the Tannic Acid inhibition samples is seen in Figure S in the 
appendix.  A photograph of the Humic Acid inhibition samples is seen in Figure T in the 
appendix.   
Following addition directly to the PCR tubes, humic acid was expected to have an effect 
on the samples amplification process.  Tannic acid was suspected to have an effect; however, the 
severity of inhibition that occurred was unexpected.  The extreme nature of discoloration that 
occurred with directly adding humic acid and tannic acid to the amplification process greatly 
exaggerates the most likely encounters with these inhibitors in casework samples.  The inhibitor 
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will not be added directly to the amplification process in casework samples.  The process of 
extraction is designed to alleviate the affect of inhibitors, which was not tested in this research. 
Hematin. 
The PowerPlex® 16 HS system demonstrated a great deal of tolerance within the hematin 
study.  Hematin was added directly to the PCR tube to ensure potential inhibition had the 
opportunity to occur.  The level of inhibition on the multiplexing system most likely outweighs 
any level of inhibition a casework sample may be presented with.  The color of the inhibitor 
when it was formulated indicated a level of inhibition would be seen.  The 1000 µM 
concentration of hematin produced a completely black substance.  A better understanding of the 
extreme nature of the coloration is evident through the undistinguishable label written in sharpie 
on the 2.0 ml microcentrifuge tube.  A photograph of the Hematin inhibition samples is seen in 
Figure U in the appendix.  As the serial dilutions were made, the tint gradually lightened; 
however, the final concentration of 125 µM still presented a substance encompassing a dark 
coloration.  The PowerPlex® 16 HS system was able to produce amplification of all 16 loci with 
500 µM of hematin added directly to the reaction. 
Conclusions 
 Following the internal validation process, the following parameters were established for 
all subsequent samples analyzed utilizing the PowerPlex® 16 HS system.  The detection 
threshold was set at 95 RFU.  The dynamic range of the system was 0.63 ng – 0.16 ng of input 
DNA.  The sensitivity of the multiplexing system was 0.16 ng.  The stochastic threshold was set 
at 750 RFU.  The precision and reproducibility of the system were successful.  Marker specific 
stutter ratios were established for each locus.  Cross-contamination was not found within the 
instrumentation or set-up procedures.  The mixture study led to indistinguishable major and 
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minor contributors for the ratios tested, except 1:19 and 19:1.  The mock case was successfully 
analyzed and confirmed by a known independent reviewer. 
At the conclusion of this research, the PowerPlex® 16 HS system is not recommended for 
forensic analysis of challenging DNA samples.  It adequately analyzed single-source DNA 
samples.  However, due to the imbalance in peak heights the system restricts the analyst in 
interpretation scenarios. 
Following the environmental inhibitor studies, the PowerPlex® 16 HS system displayed 
great tolerance to known amplification inhibitors.  The PowerPlex® 16 HS system showed it was 
capable of analyzing DNA samples through the PCR process with known inhibitors.  The 
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Applied Biosystems  Buffer (10X) with EDTA  402824 
Promega Corporation  DTT (Dithiothreitol)  Molecular Biology Grade V3151 
Applied Biosystems 3130 & 3100 – Avant 
Capillary Array 
36cm 4333464 
MP Biomedicals, LLC 
(Solon, OH, USA) 
Hematin Porcine Powder 198969 
Fisher Science Education 
(Hanover Park, IL) 
Tannic Acid Powder 1401-55-4 
Alfa Aesar, A Johnson 
Matthey Company (Ward 
Hill, MA, USA) 
Humic Acid Powder 1415-93-6 
Sigma-Aldrich (St. Louis, 
MO, USA) 
Sodium Hydroxide, pellets 97+%, A.C.S. reagent 221465-500G 
Whatman Human ID Bloodstain 
Card BFC 180 
 WB100014 
Applied Biosystems Plate Septa 96-well  4315933 
Applied Biosystems MicroAmp Optical 96-
well Reaction Plate 
 N801-0560 
Diversified Biotech 
(Boston, MA, USA) 
Teeny Tough Tags  TT-TNY 
USA Scientific (Ocala, 
FL, USA) 
TipOne 0.5-20 µl Filter 
Tips 
 1121-4810 
USA Scientific TipOne 1-100 µl Beveled 
Filter Tips 
 1120-1840 
USA Scientific TipOne 101-1000 µl Filter 
Tips 
 1126-7810 
USA Scientific Seal Rite 0.2 ml Indiv. 
Thin Wall PCR Tubes 
with attached Dome Cap 
 1602-4300 
USA Scientific Seal Rite 0.5 ml Natural 
Microcentrifuge Tubes 
 1605-0000 
USA Scientific Seal Rite 2.0 ml Natural 
Microcentrifuge Tubes 
 1620-2700 
Fisher Scientific 1 L BP561-1 Water Sterile 1609-47-8 
 
Table V.  List the instrumentation and equipment used to conduct this research.  The 
manufacturer is listed, along with the title of the item or instrument, and catalog number or serial 
number associated with the item. 
